WO2016206638A1 - Wound dressing containing silver chelate fiber - Google Patents

Wound dressing containing silver chelate fiber Download PDF

Info

Publication number
WO2016206638A1
WO2016206638A1 PCT/CN2016/087192 CN2016087192W WO2016206638A1 WO 2016206638 A1 WO2016206638 A1 WO 2016206638A1 CN 2016087192 W CN2016087192 W CN 2016087192W WO 2016206638 A1 WO2016206638 A1 WO 2016206638A1
Authority
WO
WIPO (PCT)
Prior art keywords
silver
fiber
treatment
fibers
wound dressing
Prior art date
Application number
PCT/CN2016/087192
Other languages
French (fr)
Chinese (zh)
Inventor
王晓东
陶炳志
莫小慧
姜猛进
徐建军
宋永娇
Original Assignee
佛山市优特医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 佛山市优特医疗科技有限公司 filed Critical 佛山市优特医疗科技有限公司
Publication of WO2016206638A1 publication Critical patent/WO2016206638A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M11/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
    • D06M11/58Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with nitrogen or compounds thereof, e.g. with nitrides
    • D06M11/64Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with nitrogen or compounds thereof, e.g. with nitrides with nitrogen oxides; with oxyacids of nitrogen or their salts
    • D06M11/65Salts of oxyacids of nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Textile Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicinal Preparation (AREA)

Abstract

A wound dressing containing silver chelate fibers has a single-layer structure or a multi-layer structure. The wound dressing having a single-layer structure is manufactured by blending and spinning silver chelate fibers and silver-free fibers. The wound dressing having a multi-layer structure comprises a silver chelate fabric and a silver-free fabric, and the silver chelate fabric is manufactured by blending and spinning silver chelate fibers and silver-free fibers. The weight of the silver-free fibers is 5-95 wt% of the total weight of the wound dressing. The silver chelate fibers contained in the wound dressing has a silver content of 1-35 wt%. The wound dressing has an areal weight of 25-750 g/m2, moisture absorption of 5 g/100 cm2 and above and wet strength of 0.3 N/cm and above.

Description

一种含有螯合银纤维的伤口敷料Wound dressing containing chelated silver fiber 技术领域Technical field
本发明涉及一种敷料,具体涉及一种含有螯合银纤维的伤口敷料。The present invention relates to a dressing, and in particular to a wound dressing comprising a chelated silver fiber.
背景技术Background technique
在护理慢性伤口时,选择一种可以有效吸收伤口渗出液和防止伤口感染的敷料是治疗慢性伤口的关键因素。由于慢性伤口愈合周期长,在治疗的过程中很容易引起伤口感染,尤其是溃疡性伤口最容易产生微生物感染,这延长了伤口的愈合时间,因此,选择一种能长时间抗菌的伤口敷料是慢性伤口愈合的关键之一。In the care of chronic wounds, the choice of a dressing that effectively absorbs wound exudate and prevents wound infection is a key factor in the treatment of chronic wounds. Due to the long healing period of chronic wounds, it is easy to cause wound infection during the treatment process, especially ulcerative wounds are most prone to microbial infection, which prolongs the healing time of the wound. Therefore, it is a wound dressing that can be antibacterial for a long time. One of the keys to chronic wound healing.
目前,能抗菌的伤口敷料主要有两种类型,第一种是使用天然抗菌材料如壳聚糖纤维制成的织物,第二种是向现有吸湿或凝胶材料(如纤维)中添加抗菌剂如银物质和/或聚六亚甲基双胍(PHMB)等而制成的织物。由于第二种伤口敷料可以兼顾伤口愈合所需要的杀菌和吸湿的要求而得到广泛的推广和应用。At present, there are two main types of antibacterial wound dressings. The first one is a fabric made of natural antibacterial materials such as chitosan fibers, and the second is an antibacterial or gel material (such as fiber). A fabric made of a silver material and/or polyhexamethylene biguanide (PHMB) or the like. Because the second wound dressing can meet the requirements of sterilization and moisture absorption required for wound healing, it has been widely promoted and applied.
目前的含银敷料主要分为两大类,即金属型含银敷料和离子型含银敷料。金属型含银敷料中的银在所述敷料中以金属单质的形式存在,如镀银材料或纳米银粒子。而离子型含银敷料中的银在所述敷料中以银离子的形式存在并与该敷料的其他组分形成银化合物或络合物;在遇到液体如伤口分泌液时,离子型含银敷料中的银离子会被释放出来。含银敷料中的银单质或银离子通过破坏细菌的细胞膜或细菌体中的酶蛋白来降低细菌生物活性酶的活性,从而实现含银敷料的抗菌效果。The current silver-containing dressings are mainly divided into two major categories, namely metal-type silver-containing dressings and ionic silver-containing dressings. The silver in the metallic silver-containing dressing is present in the dressing as a metal element, such as a silver plated material or a nanosilver particle. While the silver in the ionic silver-containing dressing is present in the dressing as silver ions and forms a silver compound or complex with other components of the dressing; in the case of liquids such as wound exudates, the ionic silver-containing Silver ions in the dressing will be released. The silver elemental or silver ions in the silver-containing dressing reduce the activity of the bacterial bioactive enzyme by destroying the bacterial cell membrane or the enzyme protein in the bacterial body, thereby realizing the antibacterial effect of the silver-containing dressing.
美国专利US7,385,101B2公开了一种适用于伤口敷料的抗菌纺织材料及其伤口敷料,该伤口敷料是将表面带有金属银涂层的纺织纤维与海藻酸盐纤维混合,通过非织造方法制得的一种含银量高达8wt%且具有长时间抗菌效果的伤口敷料。但是,这种敷料金属银涂层的银单质释放率低,这降低了该伤口敷料的抗菌效果。并且,这种带有金属银涂层的纺织纤维吸湿性差,这致使上述伤口敷料不利于伤口的愈合。U.S. Patent No. 7,385,101 B2 discloses an antibacterial textile material suitable for use in a wound dressing and a wound dressing thereof which is obtained by mixing a textile fiber having a metallic silver coating on the surface with alginate fibers by a nonwoven method. A wound dressing having a silver content of up to 8 wt% and having a long-term antibacterial effect. However, this dressing metallic silver coating has a low silver element release rate which reduces the antimicrobial effect of the wound dressing. Moreover, such textile fibers with a metallic silver coating have poor hygroscopicity, which makes the wound dressing described above unfavorable for wound healing.
中国专利申请200510084006.2公开了一种纳米银抗菌敷料及其制备方法和应用,该发明采用浸轧方法使含有纳米银的涂覆液涂覆在织物上,制成纳米银含量为0.05-2.9wt%的敷料。该纳米银抗菌敷料在治疗感染性伤口时,具有明显的杀灭或抑制病原菌的能力,可以加速伤口的愈合。但是,上述纳米银抗菌敷料中的银是单质银,其银释放率 较低,对慢性伤口感染,尤其是溃疡伤口中常见的重度伤口感染的治疗效果较差,无法满足市场的需要。Chinese Patent Application No. 200510084006.2 discloses a nano silver antibacterial dressing and a preparation method and application thereof. The invention adopts a padding method to coat a coating liquid containing nano silver on a fabric to prepare a nano silver content of 0.05-2.9 wt%. Dressing. The nano silver antibacterial dressing has obvious ability to kill or inhibit pathogenic bacteria when treating infectious wounds, and can accelerate wound healing. However, the silver in the above nanosilver antibacterial dressing is elemental silver, and its silver release rate Lower, the treatment of chronic wound infections, especially the severe wound infections common in ulcer wounds, is ineffective and cannot meet the needs of the market.
中国专利申请CN101187153A公开了一种海藻酸钙纤维快速添加银离子杀菌的简易方法,该方法是将海藻酸钙纤维浸泡在含银离子化合物与羧甲基纤维素纳粉体的混合液中,使海藻酸钙纤维表面吸附含银物质。但这种吸附是物理吸附,含银物质在所述纤维的后续加工的过程中容易脱离,这导致通过上述简易方法制得的敷料的含银量低,从而导致该敷料的抗菌效果不理想。Chinese patent application CN101187153A discloses a simple method for rapidly adding silver ion sterilization to calcium alginate fibers by immersing calcium alginate fibers in a mixture of a silver ion-containing compound and a carboxymethylcellulose nanopowder. The surface of the calcium alginate fiber adsorbs silver-containing substances. However, this adsorption is physical adsorption, and the silver-containing substance is easily detached during the subsequent processing of the fiber, which results in a low silver content of the dressing prepared by the above simple method, resulting in an unsatisfactory antibacterial effect of the dressing.
欧洲专利EP1882482B1公开了一种将纤维浸泡于含银离子溶液的方法,其所制得的敷料也属于离子银类型。但是,该方法在处理过程中需要使用有机溶剂,而通过该方法所制备的敷料中有机溶剂的残留会导致敷料对人体产生不良影响。此外,这种方法所制备的敷料湿强度特别低,不利于伤口敷料在更换时的整片去除。European Patent EP 1 882 482 B1 discloses a method of immersing fibers in a solution containing silver ions, which is also of the ionic silver type. However, this method requires the use of an organic solvent during the treatment, and the residue of the organic solvent in the dressing prepared by the method causes the dressing to have an adverse effect on the human body. In addition, the dressing prepared by this method has a particularly low wet strength, which is detrimental to the overall removal of the wound dressing during replacement.
聚六亚甲基双胍(PHMB)是环保型高分子聚合物杀菌消毒剂,具有杀菌效果明显、作用速度快、性质稳定、易溶于水的优良性能。Polyhexamethylene biguanide (PHMB) is an environmentally friendly polymer disinfectant with excellent bactericidal effect, fast action, stable nature and easy to dissolve in water.
中国专利申请201010538137.4公开了一种具有抗菌作用的纤维类伤口敷料及其制备方法,该敷料是由表面喷涂有聚六亚甲基双胍溶液的纤维制成的织物,所制得的敷料既有抗菌性能,又有吸湿保湿性能,对慢性伤口具有显著的治疗效果。但是,喷涂有PHMB的敷料表面会发黏,不利于医护人员的使用。Chinese Patent Application No. 201010538137.4 discloses a fibrous wound dressing having an antibacterial effect and a preparation method thereof, which is a fabric made of fibers coated with a polyhexamethylene biguanide solution, and the prepared dressing has both antibacterial properties. Performance, moisture absorption and moisturizing properties, has a significant therapeutic effect on chronic wounds. However, the surface of the dressing coated with PHMB will be sticky, which is not conducive to the use of medical personnel.
因此,开发出一种高吸湿性、高湿强度和能长时间抗菌的伤口敷料是目前治疗慢性伤口亟需解决的难题。Therefore, the development of a highly hygroscopic, high-humidity and long-term antibacterial wound dressing is currently a difficult problem to be solved in the treatment of chronic wounds.
发明内容Summary of the invention
本发明的一个目的在于提供一种含有螯合银纤维的伤口敷料,其不但具有长时间抗菌的功能还具有高吸湿性和高湿强度的特点,从而解决伤口敷料性能不足这一治疗慢性伤口的难题。An object of the present invention is to provide a wound dressing containing a chelated silver fiber, which has the characteristics of long-term antibacterial function and high hygroscopicity and high wet strength, thereby solving the problem of insufficient wound dressing performance for treating chronic wounds. problem.
本发明的另一目的是提供一种制备上述含有螯合银纤维的伤口敷料的方法。Another object of the present invention is to provide a method of preparing the above wound dressing containing chelating silver fibers.
为了实现上述目的,本发明的一个方面提供了一种含有螯合银纤维的伤口敷料,所述伤口敷料为单层结构或多层结构,其中,In order to achieve the above object, an aspect of the invention provides a wound dressing comprising a chelated silver fiber, the wound dressing being a single layer structure or a multilayer structure, wherein
所述单层结构的伤口敷料由螯合银纤维与不含银纤维通过混纺方式制成; The single layer structure wound dressing is made by blending silver fiber with silver fiber without blending;
所述多层结构的伤口敷料包括螯合银织物和不含银织物,该伤口敷料采用如下方式制成:首先分别将螯合银纤维与不含银纤维通过混纺方式制成织物,然后将上述制成的螯合银织物复合在上述制成的不含银织物上;The multi-layered wound dressing comprises a chelated silver fabric and a silver-free fabric, and the wound dressing is prepared by first forming a fabric by blending silver fibers with silver fibers, and then fabricating the above. The prepared chelated silver fabric is compounded on the silver-free fabric prepared above;
所述不含银纤维的重量是所述伤口敷料总重量的5-95wt%。The weight of the silver-free fiber is from 5 to 95% by weight based on the total weight of the wound dressing.
在上述技术方案中,所述混纺方式包括织造和非织造方式,其中织造方式包括机织、针织等方式。In the above technical solution, the blending method includes a weaving and a non-woven method, wherein the weaving method includes a weaving, knitting, and the like.
在上述多层结构的伤口敷料中,可以根据需要将所述螯合银织物设置在所述伤口敷料的内层(即伤口接触层)、中间层或外层(即远离伤口层)。当将所述螯合银织物设置为伤口接触层时,所述螯合银织物中释放出的银离子就可以杀灭伤口中的微生物;当将所述螯合银织物设置为远离伤口层时,可以将微生物阻挡在伤口之外,预防伤口感染;当将所述螯合银织物设置为中间层时,可以达到既杀灭伤口分泌液中的微生物又阻挡外面的微生物侵入的目的。无论将所述螯合银织物设置为伤口接触层、中间层或远离伤口层,都可以将这些层设置为岛形。In the above-described multi-layered wound dressing, the chelated silver fabric may be placed on the inner layer (ie, the wound contact layer), the intermediate layer, or the outer layer (ie, away from the wound layer) of the wound dressing as needed. When the chelated silver fabric is disposed as a wound contact layer, the silver ions released from the chelated silver fabric can kill microorganisms in the wound; when the chelated silver fabric is placed away from the wound layer The microorganism can be blocked outside the wound to prevent wound infection; when the chelated silver fabric is set as the intermediate layer, the purpose of killing both the microorganisms in the wound secretion and blocking the invasion of microorganisms outside can be achieved. Whether the chelated silver fabric is disposed as a wound contact layer, an intermediate layer, or away from the wound layer, the layers may be disposed in an island shape.
另外,上述多层结构的伤口敷料,除包括所述螯合银织物和不含银织物之外,还可以包括片状材料层,其包括但不限于聚氨酯膜、水凝胶膜、离型膜等。In addition, the wound dressing of the above multilayer structure may include a sheet material layer including but not limited to a polyurethane film, a hydrogel film, a release film, in addition to the chelated silver fabric and the silver-free fabric. Wait.
一般来说,对于感染较严重的伤口,需要使用含银量多一些的伤口敷料,以保证该伤口敷料可以释放足够多的银离子来杀灭微生物,特别是对那些需要把伤口敷料留置在伤口上较长时间的情况,比如7天,甚至14天的情况,所述伤口敷料中的银离子总量就成为能否有效消除伤口感染的关键。因此,为了满足抗菌要求,需要使伤口敷料有较高的银离子含量。本发明稍后提出的制备含螯合银纤维的伤口敷料的方法可以使本发明提出的伤口敷料中螯合银纤维的含银量最高达到35wt%,即所述螯合银纤维中银离子的质量分数最高可以达到35wt%。由于螯合银纤维中的银离子遇水即能被释放,从实用角度和生产成本角度考虑,螯合银纤维的含银量一般不需要达到35wt%。对于轻微感染的伤口或为了预防伤口感染,所使用的伤口敷料的含银量可以小一点。在一些伤口敷料实施例中,所述螯合银纤维的含银量为1-20wt%。在一些螯合银纤维中银离子分布更加均匀的伤口敷料实施例中,所述螯合银纤维的含银量为1-10wt%。In general, for wounds with more serious infections, a wound dressing containing more silver is needed to ensure that the wound dressing can release enough silver ions to kill the microorganisms, especially for those who need to leave the wound dressing in the wound. In the case of a long time, such as 7 days or even 14 days, the total amount of silver ions in the wound dressing becomes the key to effectively eliminate wound infection. Therefore, in order to meet the antibacterial requirements, it is necessary to have a higher silver ion content in the wound dressing. The method for preparing a silver dressing containing wound dressing according to the present invention can make the silver content of the chelated silver fiber in the wound dressing of the present invention up to 35 wt%, that is, the quality of the silver ion in the chelated silver fiber. The score can be up to 35wt%. Since silver ions in the chelated silver fiber can be released in contact with water, the silver content of the chelated silver fiber generally does not need to be 35 wt% from the viewpoint of practical use and production cost. For slightly infected wounds or to prevent wound infections, the wound dressing used may contain less silver. In some wound dressing embodiments, the chelated silver fibers have a silver content of from 1 to 20% by weight. In some wound dressing embodiments in which the silver ion distribution is more uniform in some of the chelated silver fibers, the chelated silver fibers have a silver content of from 1 to 10% by weight.
螯合作用是指中心离子同时和某些多齿配体形成两个或两个以上 的配位键。一般来讲,这样的多齿配体都是一些含氮(N)、氧(O)和硫(S)的配体。螯合物是一种由金属离子与其他分子形成两个或两个以上配位键的化合物。螯合银纤维是把银离子通过化学键的方式结合在纤维上,以满足银材料稳定不易脱落的要求。由于螯合作用可以将大量的银离子结合在特定纤维上,从而实现提高纤维及敷料含银量的目的。与一般的物理吸附如表面喷涂不同,螯合作用是一种化学键结合,银离子与纤维形成螯合作用后,一般不容易在后续加工过程中从纤维上脱落下来。Chelation refers to the formation of two or more central ions simultaneously with certain polydentate ligands. Coordination key. Generally, such polydentate ligands are ligands containing nitrogen (N), oxygen (O) and sulfur (S). A chelate is a compound in which two or more coordinate bonds are formed by metal ions with other molecules. The chelated silver fiber is bonded to the fiber by means of a chemical bond to satisfy the requirement that the silver material is stable and not easy to fall off. Since chelation can combine a large amount of silver ions on a specific fiber, the purpose of increasing the silver content of the fiber and the dressing can be achieved. Unlike general physical adsorption, such as surface coating, chelation is a chemical bond. After silver ions are chelated with fibers, they are generally not easily detached from the fibers during subsequent processing.
在上述技术方案中,所述螯合银纤维中与银离子螯合的纤维为聚丙烯腈纤维(PAN纤维)或聚丙烯腈/聚乙烯醇共混纤维(PAN/PVA纤维)。这些纤维中的腈基(-CN)与银离子具有很好的螯合作用。In the above technical solution, the fiber chelated with silver ions in the chelated silver fiber is polyacrylonitrile fiber (PAN fiber) or polyacrylonitrile/polyvinyl alcohol blend fiber (PAN/PVA fiber). The nitrile group (-CN) in these fibers has a good chelation with silver ions.
此外,对这些纤维在螯合银之前进行一些预处理,可以使所述纤维与银离子产生更好的螯合作用,所述预处理包括但不限于偕胺肟化处理、多元胺处理、微孔萃取处理和表面亲水处理等。本发明将会在下文对这些预处理进行更加详细的说明。对这些纤维在螯合银之后进行一些后处理,可以改善纤维/敷料的性能,如吸湿性和敷料颜色变化,从而更有利于伤口护理,所述后处理包括但不限于羧甲基化处理、酰化处理、烷基磺酸化处理、氨溶液浸润处理和表面上油/乳化剂处理等。本发明将会在下文对这些后处理进行更加详细的说明。In addition, some pretreatment of these fibers prior to chelation of silver can result in better chelation of the fibers with silver ions, including but not limited to amidoxime treatment, polyamine treatment, micro Hole extraction treatment and surface hydrophilic treatment. These pretreatments will be described in more detail below in the present invention. These post-treatments of these fibers after chelation of the silver may improve the fiber/dressing properties, such as hygroscopicity and dressing color change, to facilitate wound care, including but not limited to carboxymethylation, Acylation treatment, alkyl sulfonation treatment, ammonia solution infiltration treatment, and surface oil/emulsifier treatment. These post-processing will be described in more detail below in the present invention.
为了进一步提高螯合银的效率,有必要选择具有一定细度和长度的纤维。在一些优选实施方式中,所述聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维的细度(即线密度)为0.1-10dtex,长度为3-125mm。In order to further increase the efficiency of chelated silver, it is necessary to select fibers having a certain fineness and length. In some preferred embodiments, the polyacrylonitrile fibers or polyacrylonitrile/polyvinyl alcohol blend fibers have a fineness (i.e., linear density) of from 0.1 to 10 dtex and a length of from 3 to 125 mm.
在上述技术方案中,所述不含银纤维可以选自海藻酸盐纤维,化学改性聚丙烯腈纤维,壳聚糖纤维,化学改性壳聚糖纤维,纤维素纤维,化学改性纤维素纤维,聚乙烯醇纤维,化学改性聚乙烯醇纤维,聚酯纤维,聚丙烯纤维,聚乙烯纤维,聚酰胺纤维,蛋白质纤维,双组分纤维中。In the above technical solution, the silver-free fiber may be selected from the group consisting of alginate fiber, chemically modified polyacrylonitrile fiber, chitosan fiber, chemically modified chitosan fiber, cellulose fiber, chemically modified cellulose. Fiber, polyvinyl alcohol fiber, chemically modified polyvinyl alcohol fiber, polyester fiber, polypropylene fiber, polyethylene fiber, polyamide fiber, protein fiber, bicomponent fiber.
考虑到伤口敷料对吸湿性能的要求较高,一般来说,所述不含银纤维优选为凝胶纤维。所述凝胶纤维的主要特点是纤维在干态下与其他纤维没有外观上的区别,但一旦遇到液体例如水、伤口分泌液等后,所述凝胶纤维能够大量吸收水分,使得该纤维横截面膨胀,或整个纤维变成胶体状,该纤维的吸湿性很高但吸湿后强度损失很多。在一些吸湿性较佳的伤口敷料实施例中,所述不含银纤维选自海藻酸盐纤维,化学改性纤维素纤维(如羧甲基纤维素纤维或羧乙基纤维素纤维),化学 改性壳聚糖纤维(酰化壳聚糖纤维或羧甲基壳聚糖纤维)中。在另一些伤口敷料实施例中,所述不含银纤维为双组分纤维,其中一个组分为低熔点纤维,将由双组分纤维制得的织物(主要是无纺布)经热烘箱处理,使双组分纤维在交叉接触处产生熔结,这样整个伤口敷料的强度,特别是湿强度都可以得到显著提高。In view of the high requirements of the wound dressing for moisture absorption properties, in general, the silver-free fiber is preferably a gel fiber. The main feature of the gel fiber is that the fiber has no appearance difference with other fibers in a dry state, but after encountering a liquid such as water, a wound exudate or the like, the gel fiber can absorb a large amount of water, so that the fiber The cross section expands, or the entire fiber becomes colloidal, and the fiber has a high hygroscopicity but a large loss of strength after moisture absorption. In some preferred absorbent dressing embodiments, the silver-free fiber is selected from the group consisting of alginate fibers, chemically modified cellulose fibers (such as carboxymethyl cellulose fibers or carboxyethyl cellulose fibers), and chemistry. Modified chitosan fiber (acylated chitosan fiber or carboxymethyl chitosan fiber). In still other wound dressing embodiments, the silver-free fiber is a bicomponent fiber, one of which is a low melting fiber, and the fabric (mainly a nonwoven fabric) made from the bicomponent fiber is treated by a hot oven. The bicomponent fibers are sintered at the cross-contact so that the strength, especially the wet strength, of the entire wound dressing can be significantly improved.
如上所述,凝胶纤维是一种比较理想的伤口敷料材料,但因为其遇水成胶,而不能由使用含银溶液浸润纤维的简单方法直接制备螯合银纤维;并且由于凝胶纤维遇水后纤维横截面膨胀或整个纤维变成胶体状,凝胶纤维的湿强度比较小。因此,本发明在优选技术方案中特别地提出了一种含有螯合银纤维的伤口敷料,其由螯合银纤维与不含银凝胶纤维通过混纺方式制成,这既解决了纯凝胶纤维敷料无法直接载银和湿强度不足的问题,同时使得含有螯合银非凝胶纤维的伤口敷料具备了一些凝胶纤维的特点,如吸湿性能和凝胶性能。As mentioned above, gel fiber is an ideal wound dressing material, but because it is gelled with water, it cannot be directly prepared from a silver fiber solution by infiltrating the fiber; and because of the gel fiber After the water, the fiber cross-section expands or the entire fiber becomes colloidal, and the wet strength of the gel fiber is relatively small. Therefore, the present invention particularly proposes a wound dressing containing chelating silver fibers in a preferred embodiment, which is prepared by blending a chelated silver fiber with a silver-free gel fiber, which solves the pure gel. Fiber dressings are not capable of directly loading silver and insufficient wet strength, while the wound dressings containing chelated silver non-gel fibers have some of the characteristics of gel fibers such as moisture absorption properties and gel properties.
在上述优选技术方案中,为了使所述伤口敷料的凝胶性能和吸湿性能不会因混纺了螯合银非凝胶纤维而下降,需要控制螯合银非凝胶纤维的比例。为了使所述伤口敷料具有明显的凝胶效果,即使所述伤口敷料能够有效地吸收液体例如水、伤口分泌液并形成凝胶,在一些伤口敷料实施例中,所述凝胶纤维的重量是所述伤口敷料总重量的50-95wt%。在一些吸湿性较佳的伤口敷料实施例中,所述凝胶纤维的重量是所述伤口敷料总重量的70-95wt%。In the above preferred embodiment, in order to prevent the gel properties and hygroscopic properties of the wound dressing from being lowered by the blending of the chelated silver non-gel fibers, it is necessary to control the ratio of the chelated silver non-gel fibers. In order for the wound dressing to have a significant gel effect, even though the wound dressing is capable of effectively absorbing liquids such as water, wound exudates and forming a gel, in some wound dressing embodiments, the weight of the gel fibers is The wound dressing is 50-95 wt% of the total weight. In some preferred absorbent dressing embodiments, the gel fibers have a weight of from 70 to 95% by weight based on the total weight of the wound dressing.
另外,本发明提供的伤口敷料的厚度(克重)可以根据伤口受感染程度和分泌物多少来选择确定。如果伤口分泌物较多,可以使用克重大些的伤口敷料,这样该敷料的吸湿性和湿强度都可以更高一些;如果伤口分泌物不多,可以使用克重小一点的伤口敷料,这样所述敷料由于厚度低而比较柔软。一般来说,本发明提供的伤口敷料的克重为25-750g/m2Additionally, the thickness (gram weight) of the wound dressing provided by the present invention can be selected based on the degree of infection of the wound and the amount of secretion. If the wound secretion is more, you can use a more important wound dressing, so that the hygroscopicity and wet strength of the dressing can be higher; if the wound secretion is not much, you can use a small weight dressing, so The dressing is relatively soft due to its low thickness. In general, the wound dressings provided herein have a basis weight of from 25 to 750 g/m 2 .
为了提高上述伤口敷料的强度,还可以在该伤口敷料中加一些加强线、纱和丝。In order to increase the strength of the wound dressing described above, it is also possible to add reinforcing threads, yarns and filaments to the wound dressing.
本发明的另一方面提供了一种制备上述含有螯合银纤维的伤口敷料的方法,该方法包括以下步骤:Another aspect of the present invention provides a method of preparing the above-described wound dressing containing a chelated silver fiber, the method comprising the steps of:
(1)将含银物质加入去离子水中制得含银溶液,其中,所述含银溶液中银离子的浓度为0.01-30wt%;(1) adding silver-containing material to deionized water to obtain a silver-containing solution, wherein the concentration of silver ions in the silver-containing solution is 0.01-30% by weight;
(2)将聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维浸泡于步骤(1) 制得的含银溶液中5-600min,并使所述含银溶液的温度保持在10-65℃,其中,所述纤维重量与含银溶液重量的比例(或称为浴比)为1:5-1:1000;(2) Soaking polyacrylonitrile fiber or polyacrylonitrile/polyvinyl alcohol blend fiber in step (1) The obtained silver-containing solution is kept for 5 to 600 minutes, and the temperature of the silver-containing solution is maintained at 10 to 65 ° C, wherein the ratio of the weight of the fiber to the weight of the silver-containing solution (or the bath ratio) is 1: 5-1:1000;
(3)将步骤(2)所得的纤维冲洗,并将其烘干或晾干,得到螯合银纤维;(3) rinsing the fiber obtained in the step (2), and drying or drying it to obtain a chelated silver fiber;
(4)将步骤(3)所得的螯合银纤维与不含银纤维通过混纺方式制备成含银织物;(4) preparing the silver-containing fabric by blending the chelated silver fiber obtained in the step (3) with the silver-free fiber;
(5)将步骤(4)所得的含银织物切成片状,然后对其进行包装和灭菌处理,即制得所述含有螯合银纤维的伤口敷料。(5) The silver-containing fabric obtained in the step (4) is cut into a sheet shape, which is then packaged and sterilized to obtain the wound dressing containing the chelating silver fibers.
根据螯合银纤维的目标含银量,可以对步骤(2)中的浸泡时间、含银溶液温度等参数进行进一步的控制。一般来说,所述含银溶液中银离子的浓度越高,则螯合银纤维中的含银量越高。步骤(2)中的浴比、含银溶液温度和浸泡时间与纤维含银量的关系也是如此。所述含银溶液的起始pH值可以控制在4-7之间。According to the target silver content of the chelated silver fiber, the parameters such as the soaking time and the temperature of the silver-containing solution in the step (2) can be further controlled. Generally, the higher the concentration of silver ions in the silver-containing solution, the higher the silver content in the chelated silver fibers. The relationship between the bath ratio in step (2), the temperature of the silver-containing solution, and the soaking time as well as the silver content of the fiber is also the same. The initial pH of the silver-containing solution can be controlled between 4 and 7.
本发明提供的制备上述含有螯合银纤维的伤口敷料的方法,特别是其中螯合银的方法简单,通过控制上述参数可以很容易地控制螯合银纤维的含银量。The present invention provides a method for preparing the above-described wound dressing containing silver fiber, in particular, a method in which silver is chelated, and the silver content of the chelated silver fiber can be easily controlled by controlling the above parameters.
在上述制备方法的一些实施例中,步骤(2)前还包括步骤(2a),步骤(2a)是对步骤(2)中采用的纤维做预处理,所述预处理为下述处理的一种或多种:In some embodiments of the above preparation method, the step (2) further comprises a step (2a), the step (2a) is a pretreatment of the fiber used in the step (2), the pretreatment being one of the following treatments Kind or more:
偕胺肟化处理;Amidoxime treatment;
多元胺处理;Polyamine treatment;
微孔萃取处理;和Microporous extraction treatment; and
表面亲水处理。The surface is hydrophilic.
在步骤(2a)中,偕胺肟化处理是使步骤(2)中所采用纤维的结构上的腈基(-C=N)还原成带有氨基的肟基-C(NH2)=N(OH),从而使这个结构中的氮原子和氧原子与银离子形成螯合环。例如,将聚丙烯腈纤维与聚乙烯醇纤维共混纺丝制得的聚丙烯腈/聚乙烯醇共混纤维进行偕胺肟化处理得到偕胺肟化聚丙烯腈/聚乙烯醇共混纤维(PAO/PVA纤维)。In the step (2a), the amidoxime treatment is to reduce the structural nitrile group (-C=N) of the fiber used in the step (2) to an amino group-containing thiol-C(NH 2 )=N. (OH), whereby the nitrogen and oxygen atoms in this structure form a chelate ring with the silver ions. For example, a polyacrylonitrile/polyvinyl alcohol blend fiber obtained by blending polyacrylonitrile fibers and polyvinyl alcohol fibers is subjected to amidoxime treatment to obtain an amidoxime polyacrylonitrile/polyvinyl alcohol blend fiber ( PAO/PVA fiber).
典型的偕胺肟化处理是将聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维浸泡在一个含有盐酸羟氨和无水碳酸钠的水溶液中。这样聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维就被偕胺肟化。所述偕胺肟化处理的温度在20-90℃,浸泡时间为10min-5h。在偕胺肟化处理过程中, 上述水溶液的pH值一般为5-8,其浴比(即纤维重量与水溶液重量的比例)在1:10-1:150之间。偕胺肟化处理的时间长短影响偕胺肟化的程度,而这个偕胺肟化程度又将影响螯合银的多少。一般来说,偕胺肟化处理时间越长,偕胺肟化的程度越高,螯合银离子效率越高。同样的原理适用于解释处理过程中的浴比。A typical guanamine deuteration treatment is to soak a polyacrylonitrile fiber or a polyacrylonitrile/polyvinyl alcohol blend fiber in an aqueous solution containing hydroxylammonium hydrochloride and anhydrous sodium carbonate. Thus, the polyacrylonitrile fiber or the polyacrylonitrile/polyvinyl alcohol blend fiber is deuterated by amidoxime. The temperature of the amidoxime treatment is 20-90 ° C, and the soaking time is 10 min -5 h. During the amidoximation treatment, The pH of the above aqueous solution is generally from 5 to 8, and the bath ratio (i.e., the ratio of the weight of the fiber to the weight of the aqueous solution) is between 1:1 and 1:150. The length of the amidoxime treatment affects the degree of guanamine deuteration, which in turn affects the amount of chelated silver. In general, the longer the amidoxime treatment time, the higher the degree of guanamine deuteration and the higher the efficiency of chelation of silver ions. The same principle applies to explaining the bath ratio during processing.
聚丙烯腈(PAN,Polyacrylonitrile)纤维可能不适合于进行偕胺肟化处理,其偕胺肟化反应条件很难控制且螯合银效率不高。聚丙烯腈纤维更适合用多元胺处理来实现其螯合银量和螯合银效率的提高。在一些制备方法实施例中,多元胺处理的具体方法是将聚丙烯腈纤维与乙二胺(EDA)在50-150℃和催化剂下(如氯化铝)反应,就可以得到可以用来螯合银的多元胺聚丙烯腈(PAEA)纤维,即1,N-乙二胺基聚丙烯腈纤维(1,N-ethylenediamino-polyacrylonitrile)。Polyacrylonitrile (PAN, Polyacrylonitrile) fiber may not be suitable for amidoxime treatment, and its amidoximation reaction conditions are difficult to control and the efficiency of chelation of silver is not high. Polyacrylonitrile fibers are more suitable for treatment with polyamines to achieve an increase in the amount of chelated silver and chelated silver. In some preparation method examples, the specific method of the polyamine treatment is to react the polyacrylonitrile fiber with ethylenediamine (EDA) at 50-150 ° C and under a catalyst (such as aluminum chloride) to obtain a chelate. A silver-containing polyamine polyacrylonitrile (PAEA) fiber, that is, 1,N-ethylenediamino-polyacrylonitrile.
对聚丙烯腈/聚乙烯醇共混纤维进行微孔处理后再进行偕胺肟化处理,该共混纤维的螯合银效率会更高一些。典型的微孔处理是先在纺丝液中加聚乙二醇1000,纺丝后再用乙醇萃取,所得共混纤维内部就会产生一些非常细小的孔隙。这种纤维再经过偕胺肟化处理,就可以螯合更多的银离子。After the microporous treatment of the polyacrylonitrile/polyvinyl alcohol blend fiber and then the amidoxime treatment, the blended fiber has a higher efficiency of chelation silver. A typical microporous treatment is to first add polyethylene glycol 1000 to the spinning solution, and then extract it with ethanol, and the resulting blended fibers will have some very fine pores inside. This fiber is then subjected to amidoxime treatment to sequester more silver ions.
此外,螯合银处理前对步骤(2)中所采用的纤维表面进行亲水处理也有利于银离子螯合。In addition, the hydrophilic treatment of the surface of the fiber used in the step (2) before the chelating silver treatment is also advantageous for silver ion chelation.
在上述制备方法的一些实施例中,步骤(3)前还包括步骤(2b),步骤(2b)是对步骤(2)制得的螯合银纤维做后处理,所述后处理为下述处理的一种或多种:In some embodiments of the above preparation method, the step (3) further comprises a step (2b), the step (2b) is a post-treatment of the chelated silver fiber obtained in the step (2), the post-treatment is as follows One or more of the treatments:
羧甲基化处理;Carboxymethylation;
酰化处理;Acylation treatment;
烷基磺酸化处理;Alkyl sulfonation treatment;
表面上油/乳化剂处理;Surface oil/emulsifier treatment;
氨溶液浸润处理;和Ammonia solution infiltration treatment; and
硫代硫酸钠溶液浸润处理。The sodium thiosulfate solution is infiltrated.
在步骤(2b)中,典型的羧甲基化处理是将螯合银纤维先经过氢氧化钠浸泡10-80min,然后再将上述纤维放在氯乙酸钠溶液中处理20-320min,温度保持在15-75℃之间,然后用酒精洗涤,烘干。所述羧甲基化处理的核心是使用尽可能低的浓度和温度,使用尽可能温和 的条件,在整个处理过程中保持溶液的pH值在7以上,从而尽量减少处理过程中银离子的损失。上述酰化处理可参见WO2012/136082中的介绍。上述烷基磺酸化处理可参见WO2012/061225中的介绍。In the step (2b), the typical carboxymethylation treatment is to soak the chelating silver fiber through sodium hydroxide for 10-80 min, and then the fiber is placed in a sodium chloroacetate solution for 20-320 min, and the temperature is maintained at Between 15-75 ° C, then wash with alcohol and dry. The core of the carboxymethylation treatment is to use as low a concentration and temperature as possible, using as mild as possible The conditions are such that the pH of the solution is maintained above 7 throughout the process to minimize the loss of silver ions during processing. The above acylation treatment can be found in the introduction in WO2012/136082. The above alkyl sulfonation treatment can be found in the introduction in WO2012/061225.
对螯合银纤维做表面上油/乳化剂处理是为了增加所述纤维的亲水性或改善纤维的抗静电性,从而增加该螯合银纤维在之后加工过程中的可加工性。The surface oil/emulsifier treatment of the chelated silver fibers is to increase the hydrophilicity of the fibers or to improve the antistatic properties of the fibers, thereby increasing the processability of the chelated silver fibers during subsequent processing.
一般来说,含银纤维见光后会变色,特别是一些离子型含银纤维,见光后会变成黑色或灰色。此外,上述纤维螯合银之后颜色也会产生变化。例如,上述纤维原来的颜色是白色,该纤维螯合银之后颜色会变深,如变成浅灰色、米色、灰色、黑色、褐色甚至红褐色等。在临床上,一般不希望伤口敷料的颜色太深,尤其不希望伤口敷料的颜色为红色或红褐色。In general, silver-containing fibers will change color when exposed to light, especially some ionic silver-containing fibers, which will turn black or gray when seen. In addition, the color of the fiber is also changed after the fiber is chelated. For example, the original color of the above fiber is white, and the color of the fiber becomes dark after chelation of silver, such as light gray, beige, gray, black, brown or even reddish brown. Clinically, it is generally undesirable to have the color of the wound dressing too deep, and in particular it is undesirable for the color of the wound dressing to be red or reddish brown.
上述步骤(2)制得的螯合银纤维在干态下颜色基本稳定,但在其遇到水或伤口分泌液时颜色会变化,变得更深一些。可以用氨溶液浸润处理步骤(2)制得的螯合银纤维来缓解其颜色变化程度。氨溶液浸润处理是将螯合银纤维用铵盐溶液处理,以进一步稳定螯合银纤维的颜色,特别是在湿态下的颜色。经过所述氨溶液浸润处理后的螯合银纤维在湿态下颜色变化小,基本上保持灰色或灰黑色。典型的氨溶液浸润处理是先将铵盐,如氯化铵、醋酸铵、碳酸铵或硫酸铵等,在水中溶解,铵盐溶液的浓度为0.01-25wt%,控制该铵盐溶液的温度在10-55℃;然后将步骤(2)制得的螯合银纤维浸泡在溶液中,浸泡时间控制在1-60min。The chelated silver fiber obtained in the above step (2) is substantially stable in color in the dry state, but the color changes and becomes deeper when it encounters water or wound secretion. The chelated silver fiber obtained by the treatment of the step (2) can be infiltrated with an ammonia solution to alleviate the degree of color change. The ammonia solution infiltration treatment treats the chelated silver fibers with an ammonium salt solution to further stabilize the color of the chelated silver fibers, particularly in the wet state. The chelated silver fiber after the ammonia solution infiltration treatment has a small color change in a wet state, and remains substantially gray or grayish black. The typical ammonia solution infiltration treatment is to first dissolve an ammonium salt such as ammonium chloride, ammonium acetate, ammonium carbonate or ammonium sulfate in water, and the concentration of the ammonium salt solution is 0.01-25% by weight, and the temperature of the ammonium salt solution is controlled. 10-55 ° C; then the chelated silver fiber prepared in step (2) is immersed in the solution, the soaking time is controlled at 1-60 min.
另外一种使伤口敷料颜色稳定的方法是对步骤(2)制得的螯合银纤维进行硫代硫酸钠溶液浸润处理。这种处理是先配置浓度为0.001-1.5mol/L的硫代硫酸钠溶液;然后将步骤(2)制得螯合银纤维浸润在该溶液中,浸润的浴比为1:5-1:500,处理温度为15-55℃,浸泡处理时间为1-85min。其中,浸润过程中溶液可以由搅拌器搅动,速度为0-100rad/min。Another method for stabilizing the color of the wound dressing is to subject the chelated silver fiber obtained in step (2) to a sodium thiosulfate solution infiltration treatment. The treatment is to firstly configure a sodium thiosulfate solution having a concentration of 0.001-1.5 mol/L; then, the chelated silver fiber obtained in the step (2) is infiltrated into the solution, and the bath ratio of the infiltration is 1:5-1: 500, the treatment temperature is 15-55 ° C, and the soaking treatment time is 1-85 min. Among them, the solution can be stirred by the agitator during the infiltration process at a speed of 0-100 rad/min.
本发明提供的伤口敷料中的螯合银纤维在进行上述氨溶液浸润处理或硫代硫酸钠溶液浸润处理之后,其颜色在正常室内光照情况下基本不再产生变化。即使在室外经过一定时间的日晒,上述螯合银纤维或含有螯合银纤维的伤口敷料的颜色也基本没有变化,而且纤维的银释放率在日晒后也基本没有变化,如实施例2中数据所示。The chelated silver fiber in the wound dressing provided by the present invention does not substantially change in color under normal indoor illumination after the above-mentioned ammonia solution infiltration treatment or infiltration treatment with sodium thiosulfate solution. Even after a certain period of outdoor sunlight, the color of the above-mentioned chelated silver fiber or the wound dressing containing the chelated silver fiber is substantially unchanged, and the silver release rate of the fiber does not substantially change after sun exposure, as in Example 2. The data is shown.
当然,也可以把聚丙烯腈纤维和聚丙烯腈/聚乙烯醇共混纤维与不 含银纤维先通过混纺方式制成织物,再将织物直接进行螯合银处理,制备成含银织物,最后将含银织物经过裁切、包装和灭菌制备成所述含有螯合银纤维的伤口敷料。Of course, it is also possible to combine polyacrylonitrile fibers and polyacrylonitrile/polyvinyl alcohol blend fibers. The silver-containing fiber is firstly made into a fabric by a blending method, and then the fabric is directly subjected to a chelation silver treatment to prepare a silver-containing fabric. Finally, the silver-containing fabric is cut, packaged and sterilized to prepare the chelated silver fiber. Wound dressing.
鉴于此,本发明的再一方面提供了一种制备上述含有螯合银纤维的伤口敷料的方法,该方法包括以下步骤:In view of this, a further aspect of the present invention provides a method of preparing the above-described wound dressing containing a chelated silver fiber, the method comprising the steps of:
(1)将聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维与不含银纤维通过混纺方式制成织物;(1) fabricating a polyacrylonitrile fiber or a polyacrylonitrile/polyvinyl alcohol blend fiber and a silver-free fiber by a blending method;
(2)将含银物质加入去离子水中制得含银溶液,其中,所述含银溶液中银离子的浓度为0.01-30wt%;(2) adding silver-containing material to deionized water to obtain a silver-containing solution, wherein the concentration of silver ions in the silver-containing solution is 0.01-30% by weight;
(3)将步骤(1)制得的织物浸泡于步骤(2)制得的含银溶液中5-600min,并使所述含银溶液的温度保持在10-65℃,其中,所述织物重量与含银溶液重量的比例(或称为浴比)为1:5-1:1000,制得含银织物;(3) soaking the fabric obtained in the step (1) in the silver-containing solution prepared in the step (2) for 5 to 600 minutes, and maintaining the temperature of the silver-containing solution at 10 to 65 ° C, wherein the fabric a ratio of weight to the weight of the silver-containing solution (or bath ratio) of 1:5-1:1000 to obtain a silver-containing fabric;
(4)将步骤(3)所得的含银织物冲洗,并将其烘干或晾干,得到螯合银织物;(4) rinsing the silver-containing fabric obtained in the step (3), and drying or drying to obtain a chelated silver fabric;
(5)将步骤(4)所得的螯合银织物切成片状,然后对其进行包装和灭菌处理,即制得所述含有螯合银纤维的伤口敷料。(5) The chelated silver fabric obtained in the step (4) is cut into a sheet shape, which is then packaged and sterilized to obtain the wound dressing containing the chelating silver fibers.
在上述制备方法的一些实施例中,步骤(1)前还包括步骤(1a),步骤(1a)是对步骤(1)中采用的聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维做预处理,所述预处理为下述处理的一种或多种:In some embodiments of the above preparation method, before the step (1), the step (1a) is further included, and the step (1a) is a polyacrylonitrile fiber or a polyacrylonitrile/polyvinyl alcohol blend fiber used in the step (1). Pretreatment is performed, which is one or more of the following treatments:
偕胺肟化处理;Amidoxime treatment;
多元胺处理;Polyamine treatment;
微孔萃取处理;和Microporous extraction treatment; and
表面亲水处理。The surface is hydrophilic.
在上述制备方法的一些实施例中,步骤(4)前还包括步骤(3b),步骤(3b)是对步骤(3)制得的含银织物做后处理,所述后处理为下述处理的一种或多种:In some embodiments of the above preparation method, the step (4) further comprises a step (3b), the step (3b) is a post-treatment of the silver-containing fabric obtained in the step (3), and the post-treatment is as follows One or more of:
羧甲基化处理;Carboxymethylation;
酰化处理;Acylation treatment;
烷基磺酸化处理;Alkyl sulfonation treatment;
表面上油/乳化剂处理;Surface oil/emulsifier treatment;
氨溶液浸润处理;和 Ammonia solution infiltration treatment; and
硫代硫酸钠溶液浸润处理。The sodium thiosulfate solution is infiltrated.
在上述两种制备方法的一些实施例中,偕胺肟化处理具体包括下述步骤:In some embodiments of the above two preparation methods, the amidoximation treatment specifically comprises the following steps:
(1)将所述聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维浸泡于含有盐酸羟氨和无水碳酸钠的水溶液中10-300min,其浸泡的浴比为1:10-1:150,并使所述溶液的温度保持在20-90℃,使所述溶液的pH值保持在5-8;(1) Soaking the polyacrylonitrile fiber or polyacrylonitrile/polyvinyl alcohol blend fiber in an aqueous solution containing hydroxylamine hydrochloride and anhydrous sodium carbonate for 10-300 min, and the bath ratio of the soaking is 1:10-1 : 150, and the temperature of the solution is maintained at 20-90 ° C, the pH of the solution is maintained at 5-8;
(2)对浸泡处理后的纤维进行干燥。(2) Drying the fibers after the immersion treatment.
在上述两种制备方法的一些实施例中,多元胺处理具体包括下述步骤:In some embodiments of the above two preparation methods, the polyamine treatment specifically comprises the following steps:
(1)将所述聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维浸泡于多元胺溶液中,并使所述溶液的温度保持在50-150℃;(1) the polyacrylonitrile fiber or polyacrylonitrile / polyvinyl alcohol blend fiber is immersed in a polyamine solution, and the temperature of the solution is maintained at 50-150 ° C;
(2)将催化剂加入至步骤(1)中的多元胺溶液中,使所述纤维和多元胺在催化剂的作用下反应0.5-10h;(2) The catalyst is added to the polyamine solution in step (1), the fiber and the polyamine are reacted under the action of a catalyst for 0.5-10 h;
(3)将浸泡处理后的纤维用酒精洗涤,并将洗涤后的纤维干燥;(3) washing the fiber after the immersion treatment with alcohol, and drying the washed fiber;
其中,所述多元胺优选为乙二胺。Wherein the polyamine is preferably ethylenediamine.
在上述两种制备方法的一些实施例中,所述含银物质可以选自下述银化合物中的一种或多种:硝酸银;氯化银;硫酸银;碳酸银;醋酸银;乳酸银;溴化银;和磷酸锆钠银。In some embodiments of the above two preparation methods, the silver-containing substance may be selected from one or more of the following silver compounds: silver nitrate; silver chloride; silver sulfate; silver carbonate; silver acetate; silver lactate Silver bromide; and silver zirconium phosphate.
理论上讲,凡是水溶性的银化合物,或者是在水中有银离子释放的银化合物,都可以用来制备银离子水溶液,如硝酸银、氯化银、硫酸银、碳酸银、磷酸锆钠银等,但是比较理想的银化合物是硝酸银。因为硝酸银是100%水溶性的。可以实现比较高的银材料利用率。例如,硝酸银的含银量为63.5wt%,所有的硝酸银都可以溶解在适量的水中。因此配置1000mL含0.1wt%银离子的溶液需要1.57g硝酸银。典型的磷酸锆钠银产品有Alphasan,其含银量可能有10%,但是磷酸锆钠银不能把所有银离子都释放出来,因此实现0.1%银离子浓度的水溶液需要大量的含银化合物,而且需要不断测试溶液中的含银量,如果不足还需要继续添加含银材料直至达到所需的银离子浓度。In theory, any water-soluble silver compound, or a silver compound released by silver ions in water, can be used to prepare silver ion aqueous solutions, such as silver nitrate, silver chloride, silver sulfate, silver carbonate, sodium zirconium phosphate. Etc. But the preferred silver compound is silver nitrate. Because silver nitrate is 100% water soluble. A relatively high utilization rate of silver material can be achieved. For example, silver nitrate has a silver content of 63.5 wt%, and all of the silver nitrate can be dissolved in an appropriate amount of water. Therefore, the configuration of 1000 mL of a solution containing 0.1 wt% of silver ions requires 1.57 g of silver nitrate. A typical sodium zinc zirconium phosphate product is Alphasan, which may have a silver content of 10%, but sodium zirconium phosphate does not release all silver ions, so an aqueous solution that achieves a concentration of 0.1% silver ions requires a large amount of silver-containing compounds, and It is necessary to continuously test the amount of silver in the solution. If it is insufficient, it is necessary to continue adding the silver-containing material until the desired concentration of silver ions is reached.
本发明提供的方法在螯合银的过程中使用去离子水作为溶剂,不使用其它分散剂和有机溶剂。只要按照要求的银离子浓度,将上述银化合物加在去离子水中搅拌即可制得相应的含银溶液。 The method provided by the present invention uses deionized water as a solvent in the process of chelation of silver without using other dispersants and organic solvents. The silver-containing solution can be prepared by adding the above silver compound to deionized water in accordance with the required silver ion concentration.
与现有技术相比,通过对制得上述伤口敷料的混纺纤维的选择及敷料制备过程的控制,本发明提供的含有螯合银纤维的伤口敷料具有较高的吸湿性,可以达到5g/100cm2及以上。此外,与其他吸湿敷料比较,本发明提供的伤口敷料具有较高的湿强度,一般在0.3N/cm以上;而美国专利6,897,341B2的代表产品是Aquacel Ag,其湿强度只有0.1N/cm左右。本发明提供的含有螯合银纤维的伤口敷料主要用于慢性伤口,例如静脉瘀血性溃疡、压迫性溃疡和糖尿病足部溃疡以及其他慢性溃疡等。Compared with the prior art, the wound dressing containing the chelating silver fiber provided by the present invention has high hygroscopicity and can reach 5g/100cm by controlling the selection of the blended fiber for preparing the above wound dressing and controlling the preparation process of the dressing. 2 and above. In addition, compared with other absorbent dressings, the wound dressings provided by the present invention have a higher wet strength, generally above 0.3 N/cm; and the representative product of US Pat. No. 6,897,341 B2 is Aquacel Ag, which has a wet strength of only about 0.1 N/cm. . The wound dressings containing the chelating silver fibers provided by the present invention are mainly used for chronic wounds such as venous venous ulcers, pressure ulcers and diabetic foot ulcers, and other chronic ulcers.
附图说明DRAWINGS
图1为本发明实施例1中制得的含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维的伤口敷料对金黄色葡萄球菌在24h的抑菌圈;1 is a inhibition zone of a wound dressing containing chelating silver-containing amidoxidinated polyacrylonitrile/polyvinyl alcohol blend fiber prepared in Example 1 of the present invention against Staphylococcus aureus at 24 hours;
图2为本发明实施例3中制得的含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维的伤口敷料对金黄色葡萄球菌在24h的抑菌圈;2 is a inhibition zone of a wound dressing containing chelating silver-containing amidoxidinated polyacrylonitrile/polyvinyl alcohol blend fiber prepared in Example 3 of the present invention against Staphylococcus aureus at 24 hours;
图3为本发明实施例4中制得的螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维对金黄色葡萄球菌在24h的抑菌圈;3 is a bacteriostatic ring of a chelated silver melamine deuterated polyacrylonitrile/polyvinyl alcohol blend fiber prepared in Example 4 of the present invention against Staphylococcus aureus at 24 hours;
图4为本发明实施例10中制得的含有螯合银纤维岛形敷料结构示意图,其中:41为聚氨酯膜,42为含银5x5岛芯,43为带有贯穿孔的硅胶垫,44为离型膜;4 is a schematic view showing the structure of an island-shaped dressing containing chelating silver fibers prepared in Example 10 of the present invention, wherein: 41 is a polyurethane film, 42 is a silver-containing 5×5 island core, 43 is a silicone pad with a through hole, and 44 is Release film
图5本发明提供的伤口敷料湿强度测试方法的示意图,其中:1为样品,2为容器,3为液体,4为样品夹持器。Figure 5 is a schematic view of a wet dressing test method for a wound dressing provided by the present invention, wherein: 1 is a sample, 2 is a container, 3 is a liquid, and 4 is a sample holder.
具体实施方式detailed description
以下通过附图以及具体实施例,对本发明的技术方案作进一步具体说明。The technical solutions of the present invention are further described in detail below with reference to the accompanying drawings and specific embodiments.
实施例1Example 1
制备含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维的伤口敷料Preparation of wound dressings containing chelating silver-containing amidoxidinated polyacrylonitrile/polyvinyl alcohol blend fibers
将10g硝酸银在溶解在5000mL去离子水中,待彻底溶解后,将500g细度为2dtex并且长度为38mm的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维(即PAO/PVA纤维)放入上述硝酸银溶液中在室温下浸泡9.5h。经过2次水洗后烘干。测得上述共混纤维实际含银量为17.9wt%。10 g of silver nitrate was dissolved in 5000 mL of deionized water, and after thorough dissolution, 500 g of amidoxime polyacrylonitrile/polyvinyl alcohol blend fiber (ie, PAO/PVA fiber) having a fineness of 2 dtex and a length of 38 mm was placed. Soak in the above silver nitrate solution at room temperature for 9.5 h. After 2 washes, it is dried. The actual silver content of the above blended fibers was measured to be 17.9 wt%.
将所制的含银PAO/PVA纤维与990g羧甲基纤维素纤维(长度50mm,细度2.2dtex)混纺后经梳理、针刺制成无纺布(克重110g/m2), 然后包装、辐照灭菌,制得含有螯合银纤维的伤口敷料(样品)。测得所述伤口敷料的吸湿性为19g/100cm2,湿强度为2.0N/cm。再将样品剪成8x10mm2小块,放在涂有金黄色葡萄球菌的培养皿上,置于温度37℃培养箱内24h,观测得抑菌圈如图1所示。可以看出,培养皿底部外围已经有大量细菌繁殖,而样品底部及周边几乎没有细菌生长,证明敷料中的银离子已经杀灭了敷料底部和周边的细菌,产生了良好的抗菌效果。The prepared silver-containing PAO/PVA fiber was blended with 990 g of carboxymethyl cellulose fiber (length 50 mm, fineness 2.2 dtex), and then carded and needle-punched into a non-woven fabric (weight: 110 g/m 2 ), and then packaged. Irradiation sterilization produces a wound dressing (sample) containing chelated silver fibers. The wound dressing was measured to have a hygroscopicity of 19 g/100 cm 2 and a wet strength of 2.0 N/cm. The sample was then cut into 8× 10 mm 2 small pieces and placed on a Petri dish coated with Staphylococcus aureus, and placed in an incubator at 37 ° C for 24 hours. The inhibition zone was observed as shown in Figure 1. It can be seen that there is a large amount of bacteria on the periphery of the bottom of the culture dish, and there is almost no bacterial growth at the bottom and the periphery of the sample, which proves that the silver ions in the dressing have killed the bacteria at the bottom and the periphery of the dressing, and produced a good antibacterial effect.
实施例2Example 2
制备螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维Preparation of chelated silver amidoxime polyacrylonitrile/polyvinyl alcohol blend fibers
按下表中的数据制备硝酸银溶液,并使所述硝酸银溶液的温度保持在45℃以上,将一定量的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维(细度4.5dtex,长度100mm,颜色乳白色)按照下表中的重量分别放入不同浓度的硝酸银溶液中,处理3.5h后洗涤2次,烘干后测得纤维含银量结果见下表。Prepare a silver nitrate solution according to the data in the following table, and maintain the temperature of the silver nitrate solution above 45 ° C, and a certain amount of amidoxime polyacrylonitrile/polyvinyl alcohol blend fiber (fineness 4.5 dtex, The length is 100mm, and the color is milky white. It is placed in different concentrations of silver nitrate solution according to the weight in the table below. After washing for 3.5 hours, it is washed twice. After drying, the silver content of the fiber is measured and the results are shown in the following table.
Figure PCTCN2016087192-appb-000001
Figure PCTCN2016087192-appb-000001
所有样品在室温下避光保存7天后观察纤维颜色有点偏灰色。将上述样品的第4个样品TP677D放在阳光下晒1h,观察到日晒后相应的纤维的颜色基本没有发生变化。再将日晒前、后样品分别测试银释放率,测得结果如下表中的数据所示:All samples were observed to be slightly grayish in color after 7 days of storage at room temperature in the dark. The fourth sample TP677D of the above sample was exposed to sunlight for 1 h, and it was observed that the color of the corresponding fiber did not substantially change after the sun exposure. The silver release rate was tested separately before and after exposure to sunlight, and the results are shown in the following table:
样品sample 日晒Sun exposure 24h银释放(ppm)24h silver release (ppm) 72h银释放(ppm)72h silver release (ppm) 168h银释放(ppm)168h silver release (ppm)
TP677DTP677D no 3939 5454 112112
TP677D TP677D 1h1h 4141 5858 116116
实施例3Example 3
制备含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维的伤口敷料Preparation of wound dressings containing chelating silver-containing amidoxidinated polyacrylonitrile/polyvinyl alcohol blend fibers
按照实施例2中TP677B方法,制备100g含有螯合银的偕胺肟化 聚丙烯腈/聚乙烯醇共混纤维,测得纤维含银量9.5wt%。Preparation of 100 g of amide containing chelating silver according to the method of TP677B in Example 2 The polyacrylonitrile/polyvinyl alcohol blend fiber was found to have a silver content of 9.5 wt%.
再将所得含银纤维与900g不含银海藻酸盐纤维(钙钠型G海藻酸盐,细度2.8dtex,长度50mm)均匀混合后再经过梳理、针刺制成无纺布(克重200g/m2),然后包装、辐照灭菌。测得敷料含银量为0.89wt%。测得所述伤口敷料的吸湿性为26g/100cm2,湿强度为2.8N/cm。再将样品剪成10mm2小块,放在涂有金黄色葡萄球菌的培养皿上,置于温度37℃培养箱内24h,观测得抑菌圈如图2所示。可以看出,培养皿底部外围已经有大量细菌繁殖,而样品底部及周边几乎没有细菌生长,证明敷料中的银离子已经杀灭了敷料底部和周边的细菌,产生了良好的抗菌效果。Then, the obtained silver-containing fiber is uniformly mixed with 900 g of silver-free alginate fiber (calcium sodium type G alginate, fineness 2.8 dtex, length 50 mm), and then carded and needle-punched to form a non-woven fabric (gram weight 200 g) /m 2 ), then packaged, irradiated and sterilized. The silver content of the dressing was measured to be 0.89 wt%. The wound dressing was measured to have a hygroscopicity of 26 g/100 cm 2 and a wet strength of 2.8 N/cm. The sample was then cut into 10 mm 2 small pieces and placed on a Petri dish coated with Staphylococcus aureus, and placed in an incubator at 37 ° C for 24 h. The inhibition zone was observed as shown in Fig. 2. It can be seen that there is a large amount of bacteria on the periphery of the bottom of the culture dish, and there is almost no bacterial growth at the bottom and the periphery of the sample, which proves that the silver ions in the dressing have killed the bacteria at the bottom and the periphery of the dressing, and produced a good antibacterial effect.
实施例4Example 4
制备螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维Preparation of chelated silver amidoxime polyacrylonitrile/polyvinyl alcohol blend fibers
将0.05g硝酸银在溶解在250mL去离子水中,室温下彻底溶解后,将0.5g偕胺肟化聚丙烯腈/聚乙烯醇共混纤维(细度2dtex,长度38mm)放入液体中在室温下浸泡0.5h。经过2次水洗后烘干。测得纤维实际含银量为0.6wt%。After dissolving 0.05 g of silver nitrate in 250 mL of deionized water and thoroughly dissolving at room temperature, 0.5 g of amidoxime polyacrylonitrile/polyvinyl alcohol blend fiber (fineness 2 dtex, length 38 mm) was placed in the liquid at room temperature. Soak for 0.5h. After 2 washes, it is dried. The actual silver content of the fiber was measured to be 0.6% by weight.
再将制得的纤维剪短然后铺开成1cm2,放在涂有金黄色葡萄球菌的培养皿上,置于温度37℃培养箱内24h,观测得抑菌圈如图3所示。可以看出,培养皿底部外围已经有大量细菌繁殖,而样品底部及周边几乎没有细菌生长,证明纤维中的银离子已经杀灭了敷料底部和周边的细菌,产生了良好的抗菌效果。The prepared fiber was cut short and spread to 1 cm 2 , placed on a Petri dish coated with Staphylococcus aureus, and placed in an incubator at 37 ° C for 24 hours. The inhibition zone was observed as shown in FIG. 3 . It can be seen that there is a large amount of bacteria on the periphery of the bottom of the culture dish, and there is almost no bacterial growth at the bottom and the periphery of the sample, which proves that the silver ions in the fiber have killed the bacteria at the bottom and the periphery of the dressing, and produced a good antibacterial effect.
实施例5Example 5
制备含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维的伤口敷料Preparation of wound dressings containing chelating silver-containing amidoxidinated polyacrylonitrile/polyvinyl alcohol blend fibers
将100g硝酸银在溶解在10升去离子水中,待彻底溶解后,将1公斤偕胺肟化聚丙烯腈/聚乙烯醇共混纤维(PAO/PVA纤维)(细度3dtex)放入上述硝酸银溶液中在室温下浸泡9.5h。经过2次水洗后烘干。测得纤维实际含银量为18.9wt%。然后将纤维剪成长度51mm短纤维。100 g of silver nitrate was dissolved in 10 liters of deionized water, and after completely dissolved, 1 kg of amidoxime polyacrylonitrile/polyvinyl alcohol blend fiber (PAO/PVA fiber) (fineness 3 dtex) was placed in the above nitric acid. Soak in silver solution for 9.5 h at room temperature. After 2 washes, it is dried. The actual silver content of the fiber was measured to be 18.9 wt%. The fibers were then cut into short fibers of length 51 mm.
将所制的含银PAO/PVA纤维与羧甲基纤维素纤维按照5wt%含银PAO/PVA纤维,95wt%羧甲基纤维素纤维混纺,经梳理、针刺制成克重120g/m2的无纺布,然后包装、辐照灭菌。测得所述伤口敷料的吸湿性为25.5g/100cm2,湿强度为2.3N/cm,敷料含银量为0.9wt%。 The prepared silver-containing PAO/PVA fiber and carboxymethyl cellulose fiber were blended with 5wt% silver-containing PAO/PVA fiber and 95wt% carboxymethyl cellulose fiber, and combed and needled to make a weight of 120g/m 2 . The non-woven fabric is then packaged and irradiated for sterilization. The wound dressing was measured to have a hygroscopicity of 25.5 g/100 cm 2 , a wet strength of 2.3 N/cm, and a dressing containing silver content of 0.9 wt%.
干态情况下观察到敷料的颜色是浅灰色。在正常实验室照明情况下放置24h后观察敷料颜色仍然是浅灰色,基本没有变化。将敷料放入A溶液中24h,在正常实验室照明情况下观察敷料颜色为褐色。The color of the dressing was observed to be light gray in the dry state. After standing for 24 hours under normal laboratory lighting, the color of the dressing was still light gray, with little change. The dressing was placed in solution A for 24 h and the color of the dressing was observed to be brown under normal laboratory illumination.
测试该敷料的7天银释放数据如下:The 7-day silver release data for the dressing was tested as follows:
样品sample 24h银释放24h silver release 72h银释放72h silver release 168h银释放168h silver release
实施例5Example 5 3434 4242 6161
实施例6Example 6
制备含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维的伤口敷料Preparation of wound dressings containing chelating silver-containing amidoxidinated polyacrylonitrile/polyvinyl alcohol blend fibers
将实施例4所得含银纤维与M型海藻酸盐纤维混纺,按照90wt%含银PAO/PVA纤维和10wt%海藻酸盐纤维的比例均匀混合,经梳理、针刺制成克重120g/m2的无纺布,然后包装、辐照灭菌。测得所述伤口敷料的吸湿性为11g/100cm2,湿强度为13N/cm,敷料含银量为15wt%。The silver-containing fiber obtained in Example 4 was blended with M-type alginate fiber, uniformly mixed according to the ratio of 90 wt% silver-containing PAO/PVA fiber and 10 wt% alginate fiber, and carded and needle-punched to make a weight of 120 g/m. 2 non-woven fabrics, then packaged, irradiated and sterilized. The wound dressing was measured to have a hygroscopicity of 11 g/100 cm 2 , a wet strength of 13 N/cm, and a dressing containing silver content of 15% by weight.
实施例7Example 7
制备含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维的伤口敷料Preparation of wound dressings containing chelating silver-containing amidoxidinated polyacrylonitrile/polyvinyl alcohol blend fibers
按照实施例2中TP677B方法,制备100g含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维,测得纤维含银量9.5wt。According to the TP677B method of Example 2, 100 g of amidated deuterated polyacrylonitrile/polyvinyl alcohol blend fiber containing silver chelate was prepared, and the fiber content of the fiber was measured to be 9.5 wt.
然后将所制得纤维进行硫代硫酸钠溶液浸润处理:The prepared fiber is then subjected to a sodium thiosulfate solution infiltration treatment:
1)制备硫代硫酸钠溶液,浓度为1mol/L;1) preparing a sodium thiosulfate solution at a concentration of 1 mol/L;
2)将上述螯合银纤维在常温下放入硫代硫酸钠溶液中,浴比1:50;2) The above chelated silver fiber is placed in a sodium thiosulfate solution at a normal temperature, a bath ratio of 1:50;
3)浸泡处理时间在15min;3) The soaking treatment time is 15 min;
5)处理过程中溶液用搅拌器搅动,速度在50rad/min。5) The solution was agitated with a stirrer during the process at a speed of 50 rad/min.
再将所得含银纤维与900g不含银的羧甲基纤维素纤维(DS0.3,细度2.2dtex,长度50mm)均匀混合后再经过梳理、针刺制成无纺布(克重120g/m2),然后包装、辐照灭菌。测得敷料含银量为0.8wt%。敷料吸湿性为18g/100cm2,湿强度为1.2N/cm。Then, the obtained silver-containing fiber was uniformly mixed with 900 g of silver-free carboxymethyl cellulose fiber (DS0.3, fineness 2.2 dtex, length 50 mm), and then carded and needle-punched to obtain a non-woven fabric (gram weight 120 g/ m 2 ), then packaged, irradiated and sterilized. The silver content of the dressing was measured to be 0.8% by weight. The dressing had a hygroscopicity of 18 g/100 cm 2 and a wet strength of 1.2 N/cm.
观察到敷料的颜色是浅灰色。将敷料包装在纸塑(透明)包装袋中,在正常实验室照明情况下放置24h后观察敷料颜色仍然是浅灰色。将敷料剪成5x5cm2小块,放入A溶液中24h,在正常实验室照明情况下观察敷料颜色为浅灰色。颜色比干态情况略微深一点,但没有红褐色。 The color of the dressing was observed to be light gray. The dressing was packaged in a paper-plastic (transparent) package and the color of the dressing was still light gray after 24 hours of normal laboratory lighting. The dressing was cut into 5 x 5 cm 2 pieces and placed in the A solution for 24 h. The color of the dressing was observed to be light gray under normal laboratory illumination. The color is slightly deeper than the dry state, but there is no reddish brown.
实施例8Example 8
制备含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维的伤口敷料Preparation of wound dressings containing chelating silver-containing amidoxidinated polyacrylonitrile/polyvinyl alcohol blend fibers
将实施例4所得含银纤维与丙纶纤维混纺,按照10wt%含银PAO/PVA纤维和90wt%丙纶纤维的比例均匀混合,经梳理、针刺制成克重300g/m2的无纺布,再将这个无纺布与聚丙烯酸酯高吸湿纤维无纺布(克重200g/m2)复合,然后再在这个复合材料的不含银一侧复合一层聚丙烯纺粘布(克重25g/m2)。包装、辐照灭菌后形成3层织物敷料,上层含银,中层高吸湿,底层保护敷料。测得敷料的总克重为525g/m2,吸湿性为52g/100cm2,湿强度为19N/cm,敷料含银量为1.02%。The silver-containing fiber obtained in Example 4 was blended with the polypropylene fiber, uniformly mixed according to the ratio of 10% by weight of the silver-containing PAO/PVA fiber and 90% by weight of the polypropylene fiber, and carded and needle-punched to form a nonwoven fabric having a basis weight of 300 g/m 2 . The nonwoven fabric was then compounded with a polyacrylate high-absorbent fiber nonwoven fabric (gram weight 200 g/m 2 ), and then a polypropylene spunbond fabric (gram weight 25 g) was laminated on the silver-free side of the composite material. /m 2 ). After packaging and irradiation sterilization, a three-layer fabric dressing is formed, the upper layer contains silver, the middle layer is highly hygroscopic, and the bottom layer protects the dressing. The total weight of the dressing was measured to be 525 g/m 2 , the hygroscopicity was 52 g/100 cm 2 , the wet strength was 19 N/cm, and the dressing contained silver content of 1.02%.
实施例9Example 9
制备含有螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维的伤口敷料Preparation of wound dressings containing chelating silver-containing amidoxidinated polyacrylonitrile/polyvinyl alcohol blend fibers
将实施例4所得含银纤维与双组分纤维混纺,按照5wt%含银PAO/PVA纤维、55wt%粘胶纤维和40wt%ES纤维的比例均匀混合,经梳理、加热(140℃)直接成网,制成克重35g/m2的无纺布,再将这个无纺布与聚丙烯酸酯高吸湿纤维无纺布(克重200g/m2)复合,然后再在这个复合材料的不含银一侧用针刺复合一层海藻酸盐纤维(克重85g/m2)。然后包装、辐照灭菌。测得敷料的总克重为320g/m2,吸湿性为48g/100cm2,湿强度为14N/cm,敷料含银量为0.1%。The silver-containing fiber obtained in Example 4 was blended with the bicomponent fiber, uniformly mixed according to the ratio of 5 wt% silver-containing PAO/PVA fiber, 55 wt% viscose fiber and 40 wt% ES fiber, and directly combed and heated (140 ° C). The net is made into a non-woven fabric with a weight of 35 g/m 2 , and this non-woven fabric is compounded with a polyacrylate high-absorbent fiber nonwoven fabric (gram weight 200 g/m 2 ), and then in the composite material. One side of the silver was needle-punched with a layer of alginate fiber (gram weight 85 g/m 2 ). Then packaged, irradiated and sterilized. The total weight of the dressing was measured to be 320 g/m 2 , the hygroscopicity was 48 g/100 cm 2 , the wet strength was 14 N/cm, and the dressing contained silver in an amount of 0.1%.
实施例10Example 10
制备含有螯合银纤维的岛形敷料Preparation of island shaped dressings containing chelated silver fibers
将实施例3所得无纺布伤口敷料切成5x5cm2块状,放在一个10x10cm2的透明PU膜的中部。由于该膜上有不干胶,可以将无纺布固定在该膜上。然后再在该膜和无纺布上面再盖一个10x10cm2的硅胶垫。这个硅胶垫本身带有粘性而且硅胶垫上均匀分布有贯穿整个厚度的小孔,孔径在1-3mm之间。再在硅胶垫上放置离型膜,之后包装、灭菌。The nonwoven fabric wound dressing of Example 3 was cut into 5 x 5 cm 2 pieces and placed in the middle of a 10 x 10 cm 2 transparent PU film. Since the film has a sticker, the nonwoven fabric can be fixed to the film. A 10 x 10 cm 2 silicone pad was then placed over the film and nonwoven. The silicone pad itself is viscous and has a uniform distribution of pores throughout the thickness of the silicone pad, with a pore size between 1-3 mm. The release film is placed on the silicone pad, and then packaged and sterilized.
该敷料的横截面示意图如图4所示,其中:41为聚氨酯膜,42为含银5x5岛芯,43为带有贯穿孔的硅胶垫,44为离型膜。A schematic cross-sectional view of the dressing is shown in Fig. 4, wherein: 41 is a polyurethane film, 42 is a silver-containing 5x5 island core, 43 is a silica gel pad with a through-hole, and 44 is a release film.
实施例11Example 11
氨溶液浸润处理螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维 Ammonium solution infiltration treatment of chelated silver amidoxime polyacrylonitrile/polyvinyl alcohol blend fiber
将实施例2中制备的螯合银的偕胺肟化聚丙烯腈/聚乙烯醇共混纤维浸泡在浓度为15wt%的氯化铵水溶液中,溶液温度37℃,浸泡时间30min,然后取出,水洗,干燥。The silver chelated guanamine-deuterated polyacrylonitrile/polyvinyl alcohol blend fiber prepared in Example 2 was immersed in an aqueous solution of ammonium chloride having a concentration of 15 wt%, the solution temperature was 37 ° C, the soaking time was 30 min, and then taken out. Washed and dried.
实施例12Example 12
制备含有螯合银的多元胺聚丙烯腈纤维的伤口敷料Preparation of a wound dressing containing a chelate silver-containing polyamine polyacrylonitrile fiber
将10g聚丙烯腈纤维放在盛有5000mL乙二胺圆底烧瓶中,将油浴锅预热至100-120℃,并把反应混合物转移至油浴中,等反应混合物达到100℃,加入氯化铝,开始计时,恒温回流1-5个h然后取出纤维用去离子水冲洗,烘干后得到PAEA纤维(即1,N-乙二胺基聚丙烯腈纤维);10 g of polyacrylonitrile fiber was placed in a 5000 mL ethylenediamine round bottom flask, the oil bath was preheated to 100-120 ° C, and the reaction mixture was transferred to an oil bath, and the reaction mixture was brought to 100 ° C, and chlorine was added. Aluminum, start timing, constant temperature reflux 1-5 h and then take out the fiber and rinse with deionized water, after drying to obtain PAEA fiber (ie 1, N-ethylenediamine-based polyacrylonitrile fiber);
然后把所得到的PAEA纤维浸泡在1000mL浓度为1g/L的硝酸银溶液,浸泡24h后,用去离子水洗涤,烘干后得到PAEA螯合银纤维。Then, the obtained PAEA fiber was immersed in 1000 mL of a silver nitrate solution having a concentration of 1 g/L, soaked for 24 hours, washed with deionized water, and dried to obtain PAEA chelated silver fiber.
测得纤维实际含银量为9.9wt%。The actual silver content of the fiber was measured to be 9.9 wt%.
将所制的含银PAEA纤维与羧甲基纤维素纤维按照20wt%含银PAEA纤维,80wt%羧甲基纤维素纤维混纺,经梳理、针刺制成克重为120g/m2的无纺布,然后包装、辐照灭菌。测得吸湿性为21.5g/100cm2,湿强度为2.8N/cm,敷料含银量为1.7%。The prepared silver-containing PAEA fiber and carboxymethyl cellulose fiber were blended with 20 wt% silver-containing PAEA fiber and 80 wt% carboxymethyl cellulose fiber, and carded and needle-punched to obtain a non-woven fabric having a basis weight of 120 g/m 2 . Cloth, then packaged, irradiated and sterilized. The hygroscopicity was measured to be 21.5 g/100 cm 2 , the wet strength was 2.8 N/cm, and the dressing contained silver content of 1.7%.
本发明中使用的几个主要测试方法:Several main test methods used in the present invention:
本发明实施例中所有伤口敷料的吸湿性测试参照国际标准BS EN13726-1 2002,Part 1 Aspects of Absorbency。The hygroscopicity test of all wound dressings in the examples of the present invention refers to the international standard BS EN13726-1 2002, Part 1 Aspects of Absorbency.
在上述标准中介绍了A溶液作为测试溶液。A溶液为每升溶液中含有8.298g的氯化钠和0.368g的二水氯化钙的溶液。A solution was introduced as a test solution in the above standard. The solution A was a solution containing 8.298 g of sodium chloride and 0.368 g of calcium chloride dihydrate per liter of the solution.
除另外注明外,所有含银量均以重量百分比表示。所有纤维混纺比例也是按重量计。All silver content is expressed in weight percent unless otherwise noted. All fiber blend ratios are also by weight.
为了提高湿强度测试的准确性,特别是能够更准确地比较不同样品的湿强度,在伤口敷料的湿强度进行如下步骤的测试程序:In order to improve the accuracy of the wet strength test, in particular to be able to more accurately compare the wet strength of different samples, the test procedure for the following steps is performed on the wet strength of the wound dressing:
1)将伤口敷料样本1切成2cm宽的长条试样,长度至少为7cm。在一块10×10cm2的伤口敷料上最好在与第一块试样成角90度的方向上剪裁下第二块试样,以保证同时获得纵向(MD)和横向(CD)方向的样品。1) The wound dressing sample 1 was cut into strips of 2 cm width and the length was at least 7 cm. Preferably, a second sample is cut in a 10 x 10 cm 2 wound dressing in a direction at an angle of 90 degrees to the first sample to ensure simultaneous longitudinal (MD) and transverse (CD) directions. .
2)对折试样,将其放置于上述已备有测试液3的溶液的容器2中,使用A溶液作为测试液3。该容器中的溶液高度为2+/-0.5cm。 2) A double-folded sample was placed in the container 2 in which the above-mentioned test solution 3 was prepared, and the A solution was used as the test liquid 3. The solution in the container has a height of 2 +/- 0.5 cm.
3)使试样的折叠部分置于样品夹持器4的底部,静置30秒,如图5所示。3) The folded portion of the sample was placed at the bottom of the sample holder 4 and allowed to stand for 30 seconds as shown in FIG.
4)将试样夹出容器,将其两端放入的拉伸试验机夹具的顶部和底部。4) Clamp the sample out of the container and place the ends of the tensile tester clamp at the top and bottom.
5)测试仪的两钳口距离为50mm,并设顶钳口的运行速度为100mm/min。5) The distance between the two jaws of the tester is 50mm, and the running speed of the top jaw is 100mm/min.
6)记录破坏样品的最大用力(N)。在同一时间对来源于同一敷料(10×10cm2)的两条试样进行测试,测试出来的较高强度值为CD,而较低强度值为MD。6) Record the maximum force (N) of the damaged sample. Two samples from the same dressing (10 x 10 cm 2 ) were tested at the same time, and the higher intensity values tested were CD and the lower intensity values were MD.
平均湿强度为MD和CD的平均值。The average wet strength is the average of MD and CD.
敷料含银量和银释放用中国药典中规定的原子光谱吸收仪法测试。 The silver content and silver release of the dressing were tested by the atomic absorption spectrometer method specified in the Chinese Pharmacopoeia.

Claims (16)

  1. 一种含有螯合银纤维的伤口敷料,所述伤口敷料为单层结构或多层结构,其中,A wound dressing containing a chelated silver fiber, the wound dressing being a single layer structure or a multilayer structure, wherein
    所述单层结构的伤口敷料由螯合银纤维与不含银纤维通过混纺方式制成;The single layer structure wound dressing is made by blending silver fiber with silver fiber without blending;
    所述多层结构的伤口敷料包括螯合银织物和不含银织物,该伤口敷料采用如下方式制成:首先分别将螯合银纤维与不含银纤维通过混纺方式制成织物,然后将上述制成的螯合银织物复合在不含银织物上;The multi-layered wound dressing comprises a chelated silver fabric and a silver-free fabric, and the wound dressing is prepared by first forming a fabric by blending silver fibers with silver fibers, and then fabricating the above. The resulting chelated silver fabric is composited on a silver-free fabric;
    所述不含银纤维的重量是所述敷料总重量的5-95wt%,优选为50-95wt%,更优选为70-95wt%。The weight of the silver-free fiber is from 5 to 95% by weight, preferably from 50 to 95% by weight, more preferably from 70 to 95% by weight, based on the total weight of the dressing.
  2. 根据权利要求1所述的含有螯合银纤维的伤口敷料,其中,所述螯合银纤维中银离子的质量分数为1-35wt%,优选为1-20wt%,更优选为1-10wt%。The wound dressing containing chelating silver fibers according to claim 1, wherein the silver ion in the chelated silver fibers has a mass fraction of from 1 to 35 wt%, preferably from 1 to 20 wt%, more preferably from 1 to 10 wt%.
  3. 根据权利要求1所述的含有螯合银纤维的伤口敷料,其中,所述不含银纤维选自下列纤维:海藻酸盐纤维、化学改性聚丙烯腈纤维、壳聚糖纤维、化学改性壳聚糖纤维、纤维素纤维、化学改性纤维素纤维、聚乙烯醇纤维、化学改性聚乙烯醇纤维、聚酯纤维、聚丙烯纤维、聚乙烯纤维、聚酰胺纤维、蛋白质纤维和双组分纤维,优选为凝胶纤维,更优选为化学改性壳聚糖纤维、化学改性纤维素纤维和海藻酸盐纤维。The wound dressing containing chelating silver fibers according to claim 1, wherein the silver-free fiber is selected from the group consisting of alginate fibers, chemically modified polyacrylonitrile fibers, chitosan fibers, and chemical modification. Chitosan fiber, cellulose fiber, chemically modified cellulose fiber, polyvinyl alcohol fiber, chemically modified polyvinyl alcohol fiber, polyester fiber, polypropylene fiber, polyethylene fiber, polyamide fiber, protein fiber, and double group The fiber, preferably a gel fiber, more preferably a chemically modified chitosan fiber, a chemically modified cellulose fiber, and an alginate fiber.
  4. 根据权利要求1或3所述的含有螯合银纤维的伤口敷料,其中,所述螯合银纤维中与银离子螯合的纤维为聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维。The wound dressing containing chelating silver fibers according to claim 1 or 3, wherein the fibers chelating with the silver ions in the chelating silver fibers are polyacrylonitrile fibers or polyacrylonitrile/polyvinyl alcohol blend fibers. .
  5. 根据权利要求4所述的含有螯合银纤维的伤口敷料,其中,所述聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维在与银离子螯合之前进行下述一种或多种预处理:The wound dressing containing chelating silver fibers according to claim 4, wherein the polyacrylonitrile fiber or polyacrylonitrile/polyvinyl alcohol blend fiber is subjected to one or more of the following before chelation with silver ions Pretreatment:
    偕胺肟化处理;Amidoxime treatment;
    多元胺处理;Polyamine treatment;
    微孔萃取处理;和Microporous extraction treatment; and
    表面亲水处理。The surface is hydrophilic.
  6. 根据权利要求5所述的含有螯合银纤维的伤口敷料,其中,所述偕胺肟化处理包括下述步骤: The wound dressing containing chelating silver fibers according to claim 5, wherein the amidoximation treatment comprises the steps of:
    1)将所述聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维浸泡于含有盐酸羟氨和无水碳酸钠的水溶液中10-300min,其浸泡的浴比为1:10-1:150,并使所述溶液的温度保持在20-90℃,使所述溶液的pH值保持在5-8;1) The polyacrylonitrile fiber or polyacrylonitrile/polyvinyl alcohol blend fiber is immersed in an aqueous solution containing hydroxylamine hydrochloride and anhydrous sodium carbonate for 10-300 min, and the bath ratio of the soaking is 1:10-1: 150, and maintaining the temperature of the solution at 20-90 ° C, maintaining the pH of the solution at 5-8;
    2)对浸泡处理后的纤维进行干燥。2) Dry the fibers after the immersion treatment.
  7. 根据权利要求5所述的含有螯合银纤维的伤口敷料,其中,所述多元胺处理包括下述步骤:A wound dressing comprising a chelating silver fiber according to claim 5, wherein said polyamine treatment comprises the steps of:
    1)将所述聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维浸泡于多元胺溶液中,并使所述溶液的温度保持在50-150℃;1) immersing the polyacrylonitrile fiber or polyacrylonitrile/polyvinyl alcohol blend fiber in a polyamine solution, and maintaining the temperature of the solution at 50-150 ° C;
    2)将催化剂加入至步骤(1)中的多元胺溶液中,使所述纤维和多元胺在催化剂的作用下反应0.5-10h;2) The catalyst is added to the polyamine solution in the step (1), the fiber and the polyamine are reacted under the action of the catalyst for 0.5-10 h;
    3)将浸泡处理后的纤维用酒精洗涤,并将洗涤后的纤维干燥;3) washing the fiber after the immersion treatment with alcohol, and drying the washed fiber;
    其中,所述多元胺优选为乙二胺。Wherein the polyamine is preferably ethylenediamine.
  8. 根据权利要求4所述的含有螯合银纤维的伤口敷料,其中,所述聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维在与银离子螯合之后进行下述一种或多种后处理:The wound dressing containing chelating silver fibers according to claim 4, wherein the polyacrylonitrile fiber or polyacrylonitrile/polyvinyl alcohol blend fiber is subjected to one or more of the following after sequestration with silver ions Post processing:
    羧甲基化处理;Carboxymethylation;
    酰化处理;Acylation treatment;
    烷基磺酸化处理;Alkyl sulfonation treatment;
    表面上油/乳化剂处理;Surface oil/emulsifier treatment;
    氨溶液浸润处理;和Ammonia solution infiltration treatment; and
    硫代硫酸钠溶液浸润处理。The sodium thiosulfate solution is infiltrated.
  9. 根据权利要求4所述的含有螯合银纤维的伤口敷料,其中,所述聚丙烯腈纤维或聚丙烯腈/聚乙烯醇纤维共混纤维的长度为3-125mm,线密度为0.1-10dtex。The wound dressing containing chelating silver fibers according to claim 4, wherein the polyacrylonitrile fibers or polyacrylonitrile/polyvinyl alcohol fiber blend fibers have a length of from 3 to 1.25 mm and a linear density of from 0.1 to 10 dtex.
  10. 一种制备权利要求4所述的含有螯合银纤维的伤口敷料的方法,该方法包括以下步骤:A method of preparing a silver dressing-containing wound dressing according to claim 4, the method comprising the steps of:
    (1)将含银物质加入去离子水中制得含银溶液,其中,所述含银溶液中银离子的浓度为0.01-30wt%;(1) adding silver-containing material to deionized water to obtain a silver-containing solution, wherein the concentration of silver ions in the silver-containing solution is 0.01-30% by weight;
    (2)将聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维浸泡于步骤(1)制得的含银溶液中5-600min,并使所述含银溶液的温度保持在10-65℃, 其中,所述纤维重量与含银溶液重量的比例为1:5-1:1000;(2) soaking the polyacrylonitrile fiber or the polyacrylonitrile/polyvinyl alcohol blend fiber in the silver-containing solution prepared in the step (1) for 5 to 600 minutes, and maintaining the temperature of the silver-containing solution at 10-65 °C, Wherein the ratio of the weight of the fiber to the weight of the silver-containing solution is 1:5-1:1000;
    (3)将步骤(2)所得的纤维冲洗,并将其烘干或晾干,得到螯合银纤维;(3) rinsing the fiber obtained in the step (2), and drying or drying it to obtain a chelated silver fiber;
    (4)将步骤(3)所得的螯合银纤维与不含银纤维通过混纺方式制备成含银织物;(4) preparing the silver-containing fabric by blending the chelated silver fiber obtained in the step (3) with the silver-free fiber;
    (5)将步骤(4)所得的含银织物切成片状,然后对其进行包装和灭菌处理,即制得所述含有螯合银纤维的伤口敷料。(5) The silver-containing fabric obtained in the step (4) is cut into a sheet shape, which is then packaged and sterilized to obtain the wound dressing containing the chelating silver fibers.
  11. 根据权利要求10所述的方法,其中,在步骤(2)前还包括步骤(2a),步骤(2a)是对步骤(2)中采用的纤维做预处理,所述预处理为下述处理的一种或多种:The method according to claim 10, further comprising a step (2a) before the step (2), wherein the step (2a) is a pretreatment of the fiber used in the step (2), the pretreatment being as follows One or more of:
    偕胺肟化处理;Amidoxime treatment;
    多元胺处理;Polyamine treatment;
    微孔萃取处理;和Microporous extraction treatment; and
    表面亲水处理。The surface is hydrophilic.
  12. 根据权利要求10所述的方法,其中,在步骤(3)前还包括步骤(2b),步骤(2b)是对步骤(2)中制得的螯合银纤维做后处理,所述后处理为下述处理的一种或多种:The method according to claim 10, further comprising the step (2b) before the step (3), the step (2b) of post-treating the chelated silver fiber obtained in the step (2), the post-treatment Is one or more of the following treatments:
    羧甲基化处理;Carboxymethylation;
    酰化处理;Acylation treatment;
    烷基磺酸化处理;Alkyl sulfonation treatment;
    表面上油/乳化剂处理;Surface oil/emulsifier treatment;
    氨溶液浸润处理;和Ammonia solution infiltration treatment; and
    硫代硫酸钠溶液浸润处理。The sodium thiosulfate solution is infiltrated.
  13. 一种制备权利要求4所述的含有螯合银纤维的伤口敷料的方法,该方法包括以下步骤:A method of preparing a silver dressing-containing wound dressing according to claim 4, the method comprising the steps of:
    (1)将聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维与不含银纤维通过混纺方式制成织物;(1) fabricating a polyacrylonitrile fiber or a polyacrylonitrile/polyvinyl alcohol blend fiber and a silver-free fiber by a blending method;
    (2)将含银物质加入去离子水中制得含银溶液,其中,所述含银溶液中银离子的浓度为0.01-30wt%;(2) adding silver-containing material to deionized water to obtain a silver-containing solution, wherein the concentration of silver ions in the silver-containing solution is 0.01-30% by weight;
    (3)将步骤(1)制得的织物浸泡于步骤(2)制得的含银溶液中 5-600min,并使所述含银溶液的温度保持在10-65℃,其中,所述织物重量与含银溶液重量的比例为1:5-1:1000,制得含银织物;(3) soaking the fabric obtained in the step (1) in the silver-containing solution prepared in the step (2) 5-600min, and maintaining the temperature of the silver-containing solution at 10-65 ° C, wherein the ratio of the weight of the fabric to the weight of the silver-containing solution is 1:5-1:1000, to obtain a silver-containing fabric;
    (4)将步骤(3)所得的含银织物冲洗,并将其烘干或晾干,得到螯合银织物;(4) rinsing the silver-containing fabric obtained in the step (3), and drying or drying to obtain a chelated silver fabric;
    (5)将步骤(4)所得含银织物切成片状,然后对其进行包装和灭菌处理,即制得所述含有螯合银纤维的伤口敷料。(5) The silver-containing fabric obtained in the step (4) is cut into a sheet shape, which is then packaged and sterilized to obtain the wound dressing containing the chelating silver fibers.
  14. 根据权利要求13所述的方法,其中,在步骤(1)前还包括步骤(1a),步骤(1a)是对步骤(1)中采用的聚丙烯腈纤维或聚丙烯腈/聚乙烯醇共混纤维做预处理,所述预处理为下述处理的一种或多种:The method according to claim 13, wherein the step (1a) is further included before the step (1), and the step (1a) is a combination of the polyacrylonitrile fiber or the polyacrylonitrile/polyvinyl alcohol used in the step (1). The pre-treatment of the mixed fibers is one or more of the following treatments:
    偕胺肟化处理;Amidoxime treatment;
    多元胺处理;Polyamine treatment;
    微孔萃取处理;和Microporous extraction treatment; and
    表面亲水处理。The surface is hydrophilic.
  15. 根据权利要求13所述的方法,其中,在步骤(4)前还包括步骤(3b),步骤(3b)是对步骤(3)制得的含银织物做后处理,所述后处理为下述处理的一种或多种:The method according to claim 13, wherein the step (3b) is further included before the step (4), and the step (3b) is post-processing the silver-containing fabric obtained in the step (3), and the post-treatment is One or more of the treatments:
    羧甲基化处理;Carboxymethylation;
    酰化处理;Acylation treatment;
    烷基磺酸化处理;Alkyl sulfonation treatment;
    表面上油/乳化剂处理;Surface oil/emulsifier treatment;
    氨溶液浸润处理;和Ammonia solution infiltration treatment; and
    硫代硫酸钠溶液浸润处理。The sodium thiosulfate solution is infiltrated.
  16. 根据权利要求10或13所述的方法,其中,所述含银物质选自下述银化合物中的一种或多种:硝酸银;氯化银;硫酸银;碳酸银;醋酸银;乳酸银;溴化银;和磷酸锆钠银。 The method according to claim 10 or 13, wherein the silver-containing substance is selected from one or more of the following silver compounds: silver nitrate; silver chloride; silver sulfate; silver carbonate; silver acetate; silver lactate Silver bromide; and silver zirconium phosphate.
PCT/CN2016/087192 2015-06-25 2016-06-25 Wound dressing containing silver chelate fiber WO2016206638A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201510355795.2 2015-06-25
CN201510355795 2015-06-25
CN201510433428.X 2015-07-22
CN201510433428.XA CN104958779B (en) 2015-06-25 2015-07-22 A kind of wound dressing containing chelating silver fiber

Publications (1)

Publication Number Publication Date
WO2016206638A1 true WO2016206638A1 (en) 2016-12-29

Family

ID=54212975

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/087192 WO2016206638A1 (en) 2015-06-25 2016-06-25 Wound dressing containing silver chelate fiber

Country Status (2)

Country Link
CN (1) CN104958779B (en)
WO (1) WO2016206638A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110935056A (en) * 2019-12-30 2020-03-31 山东星之诚生物科技有限公司 Preparation method of alginate dressing with high hygroscopicity
CN113980185A (en) * 2021-12-13 2022-01-28 河南汇博医疗股份有限公司 Amorphous silver-containing long-acting antibacterial hydrogel dressing with photo-crosslinking curing function and preparation method thereof
CN114687211A (en) * 2022-04-19 2022-07-01 中国科学院化学研究所 Antibacterial agent and preparation method and application thereof
CN115120771A (en) * 2022-06-30 2022-09-30 长沙海润生物技术有限公司 Pre-convergent laser sintering gauze dressing and preparation method thereof
CN115227859A (en) * 2022-07-29 2022-10-25 长沙海润生物技术有限公司 High-removal-rate bacteria-sensitive chelating silver dressing and preparation method thereof
CN115779131A (en) * 2022-10-09 2023-03-14 湖南中腾湘岳生物科技有限公司 Processing technology of medical dressing and medical dressing thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104958779B (en) * 2015-06-25 2018-03-20 佛山市优特医疗科技有限公司 A kind of wound dressing containing chelating silver fiber
CN106120052A (en) * 2016-08-12 2016-11-16 江阴市红柳被单厂有限公司 A kind of silver antibacterial high Zhi Mianfang yarn of chelate fibre and preparation method thereof
CN106087194A (en) * 2016-08-12 2016-11-09 江阴市红柳被单厂有限公司 A kind of controlled antibiotic fabric and preparation method thereof
CN107158030A (en) * 2017-06-08 2017-09-15 佛山市优特医疗科技有限公司 A kind of new silver-containing antibacterial product and preparation method thereof
CN114601631A (en) * 2017-07-11 2022-06-10 佛山市优特医疗科技有限公司 Reinforced wound dressing and preparation method thereof
CN112127148A (en) * 2020-09-01 2020-12-25 福建长庚新材料股份有限公司 High-water-absorption needle-punched non-woven decorative fabric and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002384A1 (en) * 2002-06-28 2004-01-08 Bristol-Myers Sqibb Company Antimicrobial, silver-containing wound dressing for continuous release
WO2010025224A1 (en) * 2008-08-28 2010-03-04 Tyco Healthcare Group Lp Anti-microbial fibers and related articles and methods
CN102266583A (en) * 2011-07-10 2011-12-07 东华大学 Preparation method of silver-loading modified bacterial cellulose based compound functional wet dressing
CN103463670A (en) * 2013-09-18 2013-12-25 佛山市优特医疗科技有限公司 Wound dressing containing fibers with low smelting point and production method thereof
CN103556298A (en) * 2013-10-22 2014-02-05 四川大学 Method for preparing amidoximation polyacrylonitrile latex/polyvinyl alcohol composite chelate fiber
CN104958779A (en) * 2015-06-25 2015-10-07 佛山市优特医疗科技有限公司 Chelated silver fiber-containing wound dressing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1425050T3 (en) * 2001-09-12 2008-01-07 Convatec Ltd Antibacterial wound dressing
CN1833732A (en) * 2005-03-17 2006-09-20 李毅彬 Making method of and use of antibiotic surgical dressing
CN103170004B (en) * 2012-04-23 2016-08-31 佛山市优特医疗科技有限公司 A kind of method preparing contg. silver fiber wound dressing
CN103074703A (en) * 2012-12-03 2013-05-01 佛山市优特医疗科技有限公司 Antibacterial silver-containing fiber wound dressing and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002384A1 (en) * 2002-06-28 2004-01-08 Bristol-Myers Sqibb Company Antimicrobial, silver-containing wound dressing for continuous release
WO2010025224A1 (en) * 2008-08-28 2010-03-04 Tyco Healthcare Group Lp Anti-microbial fibers and related articles and methods
CN102266583A (en) * 2011-07-10 2011-12-07 东华大学 Preparation method of silver-loading modified bacterial cellulose based compound functional wet dressing
CN103463670A (en) * 2013-09-18 2013-12-25 佛山市优特医疗科技有限公司 Wound dressing containing fibers with low smelting point and production method thereof
CN103556298A (en) * 2013-10-22 2014-02-05 四川大学 Method for preparing amidoximation polyacrylonitrile latex/polyvinyl alcohol composite chelate fiber
CN104958779A (en) * 2015-06-25 2015-10-07 佛山市优特医疗科技有限公司 Chelated silver fiber-containing wound dressing

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110935056A (en) * 2019-12-30 2020-03-31 山东星之诚生物科技有限公司 Preparation method of alginate dressing with high hygroscopicity
CN113980185A (en) * 2021-12-13 2022-01-28 河南汇博医疗股份有限公司 Amorphous silver-containing long-acting antibacterial hydrogel dressing with photo-crosslinking curing function and preparation method thereof
CN113980185B (en) * 2021-12-13 2023-09-15 河南汇博医疗股份有限公司 Amorphous silver-containing long-acting antibacterial hydrogel dressing with photocrosslinking curing function and preparation method thereof
CN114687211A (en) * 2022-04-19 2022-07-01 中国科学院化学研究所 Antibacterial agent and preparation method and application thereof
CN115120771A (en) * 2022-06-30 2022-09-30 长沙海润生物技术有限公司 Pre-convergent laser sintering gauze dressing and preparation method thereof
CN115227859A (en) * 2022-07-29 2022-10-25 长沙海润生物技术有限公司 High-removal-rate bacteria-sensitive chelating silver dressing and preparation method thereof
CN115779131A (en) * 2022-10-09 2023-03-14 湖南中腾湘岳生物科技有限公司 Processing technology of medical dressing and medical dressing thereof
CN115779131B (en) * 2022-10-09 2024-02-23 湖南中腾湘岳生物科技有限公司 Processing technology of medical dressing and medical dressing thereof

Also Published As

Publication number Publication date
CN104958779B (en) 2018-03-20
CN104958779A (en) 2015-10-07

Similar Documents

Publication Publication Date Title
WO2016206638A1 (en) Wound dressing containing silver chelate fiber
US20220273495A1 (en) Multi-Layer Wound Care Device Having Absorption and Fluid Transfer Properties
US7118761B2 (en) Method for producing a silver-containing wound care device
EP2589393B1 (en) Wound care device
JP4915530B2 (en) Antibacterial fiber, production method thereof, antibacterial fiber product containing antibacterial fiber, production method thereof and regeneration method
Chen et al. Bioactive electrospun silver nanoparticles-containing polyurethane nanofibers as wound dressings
CA2698803C (en) Wound dressing with apertured cover sheet
EP1654114B1 (en) Silver-containing wound care device, composition therefor, and method of producing
US8563447B2 (en) Silver-containing wound care device
CN105233327A (en) Quaternized chitosan fibers and moisture-absorbing antibacterial wound dressing
US20050035327A1 (en) Topical silver-based antimicrobial composition for wound care devices
JP2016533440A (en) Cellulose fiber
WO2021232870A1 (en) Copper-containing, antimicrobial and antiviral non-woven fabric and preparation method therefor
CN104324407A (en) Preparation method of nano silver chloride/chitosan fiber anti-bacterial dressing
PT2032179E (en) Wound dressing
WO2018095004A1 (en) Medical antibacterial fabric and preparation method therefor
CN111991610A (en) Antibacterial healing-promoting spunlace nonwoven dressing and preparation method thereof
RU2482883C1 (en) Method for preparing fibre polymeric composites with antimicrobial activity
WO2014000754A1 (en) Treatment method for cellulose-containing materials

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16813754

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16813754

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 23/01/2019)

122 Ep: pct application non-entry in european phase

Ref document number: 16813754

Country of ref document: EP

Kind code of ref document: A1